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  Abbreviations 
Ac Acetyl 
ACN Acetonitrile 
AcONH4 Ammonium acetate 
Boc t-Butyloxycarbonyl 
Bz Benzoyl 
Bzl Benzyl 
C18  Octadecyl 
Cam Carboxamidomethyl 
Cbo or Z Benzyloxycarbonyl 
CCK Cholecystokinin 
α-CHY α-Chymotrypsin 
DCC Dicyclohexylcarbodiimide 
DCU Dicyclohexylurea 
DCM Dichloromethane 
DMF Dimethylformamide 
DNA Deoxyribonucleic acid 
EDTA Ethylenediaminetetraacetic acid 
EtOAc Ethyl acetate 
EtOH Ethanol 
ESI Electron spraying ionization 
FAB Fast atom bombardment 
Fmoc 9-Fluorenylmethyloxycarbonyl 
h hour 
HPLC High pressure liquid chromatography 
HOBt N-hydroxybenzotriazole 
Me Methyl 
MeOH Methanol 
IV                        Abbreviations 
m.p. melting point 
min minute 
MS Mass spectrometry 
OAl Allyl ester 
OEt Ethyl ester 
OMe Methyl ester 
OPfP Pentaflurophenyl ester 
PA Penicillin amidase 
PE Petroleum ether 
PGA Penicillin G amidase 
Ph Phenyl 
Phac Phenyl acetyl 
PIM Positive ion mode 
Rf Retention factor 
RP Reversed phase 
T Temperature 
tert. tertiary  
tR retention time 
TFA Trifluoroacetic acid 
TEA Triethylamine 
TLC Thin layer chromatography 
TLN Thermolysin 
Tris  Tris-(hydroxymethyl)-aminomethane 
v volume 
 
Abbreviations of the common amino acids are used in accord with the IUPAC-IUB 
conventions (Eur. J. Biochem. 138, 9-37 (1984)). Amino acids, except glycine, are of 
the L-configuration.  
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1 Introduction 
 
Nature applies peptides, a short string of amino acids linked via amide bonds, for a 
great variety of specific functions. Peptides therefore can act as chemical messengers, 
neurotransmitters, as highly specific stimulators and inhibitors, regulating various 
life-processes. Peptides also gained importance in our everyday life. For example, a 
dipeptide derivative, aspartam, is used as sweetener; oxytocin and vasopressin have 
been available for medical purposes for many years. More recently the discovery of a 
long series of biologically active peptides together with the major application of 
peptide hormones in medicine, such as calcitonin and secretin, has given new impetus 
to synthetic peptide chemistry. 
 
The earliest modes of peptide bond formation pioneered by Curtius (1881) and 
Fischer (1901) yielded impressive but not yet practical results. Introduction of the 
amino-protecting benzyloxycarbonyl group (Bergmann and Zervas, 1932) led to a 
new era of peptide synthesis. Improvement in the methods of peptide bond formation, 
particularly the application of carbonic acid mixed anhydrides (Wieland and Bernhard, 
1951; Boissonnas, 1951) gave new impetus to peptide synthesis. The introduction of 
dicyclohexylcarbodiimide, a still unsurpassed coupling reagent (Sheehan and Hess, 
1955) had a major impact on the methodology of peptide bond formation and further 
refinement was brought about by the development of active esters (Schwyzer, 1953; 
Bodanszky, 1955). At least equally important improvements could be noted in the 
methods of protection: acid labile blocking groups were built on the stability of the 
tert. butyl cation (Carpino, 1957), such as the tert. butyloxycarbonyl (Boc) group; 
base sensitive blocking in the form of the 9-fluorenylmethyloxycarbonyl (Fmoc) 
group was introduced (Carpino and Han, 1970). Originally all synthetic peptides were 
routinely prepared by conventional solution methods, so-called classical peptide 
synthesis, that is, both reactants were soluble in the reaction media. Yet, one of the  
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most conspicuous milestones in the history of peptide synthesis is the invention of the 
solid phase peptide synthesis by Merrifield (1963).  
 
Around 110 years ago, as a consequence of van’t Hoff’s concept of the equilibrium 
constant in a reversible chemical reaction (van’t Hoff, 1898) and Ostwald’s definition 
of catalysis (Ostwald, 1901), it was concluded that the hydrolytic action of enzymes 
should be reversible and the formation of the peptide bond should be possible as well. 
In 1938, Bergmann’s group reported the first enzymatic synthesis of a peptide 
(Bergmann and Fraenkel-Conrat, 1938). Today the use of enzymes in peptide 
synthesis plays a promising role as a complement to the chemical method, in 
synthesizing peptides for research, clinical, and industrial interest (Mccoy, 2004). 
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1.1 Chemical peptide synthesis 
1.1.1 Principles 
The typically chemical formation of a peptide bond is outlined in Scheme 1.1. In 
principle, it can be reduced to four steps. 
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Scheme 1.1 Basic scheme of chemical peptide synthesis. R1, R2, side-chain    
functionalities; A, α-amino protecting group; Y, α-carboxyl protecting 
group; X, activating substituent.  
 
(1) The first step 
To ensure the synthesis of well-defined peptides, the functional groups in main-chain 
and side-chain, which are not involved in the reaction, must be selectively protected. 
In synthesis of a larger peptide, a careful planning is required to match the coupling 
methods and protection groups. 
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The most important protecting groups applied in chemical peptide synthesis are 
described as follows. 
 
Amino protecting groups 
Cbo or Z group. The benzyloxycarbonyl group (Bergmann and Zervas 1932) is an 
important amino protecting group which smoothly undergoes homolytic fission on 
catalytic hydrogenation. The process of hydrogenation is generally carried out in 
presence of a palladium catalyst deposited on charcoal. Other methods, for instance 
reduction with sodium in liquid ammonia (Sifferd and du Vigneaud, 1935) and 
acidolysis (Ben Ishai and Berger, 1952), particularly by HBr in acetic acid are also 
practised. 
 
Boc group. The t-butyloxycarbonyl group was introduced by Carpino (1957). The Boc 
group is similar to the Cbo group but the benzyl group is replaced by the tert. butyl 
group. The +I inductive effect of the three methyl groups of the Boc group give rise to 
a stable cation, hence in contrast to the Cbo group, the Boc group can be easily 
cleaved by trifluoroacetic acid. 
 
Fmoc group. The 9-fluorenylmethyloxycarbonyl group was introduced by Carpino 
and Han (1970). This group is removed from the amino group by proton abstraction 
with secondary amines. Piperidine and diethylamine are the recommended bases. 
 
Carboxyl protecting groups 
Through ester or amide, the carboxyl group can be protected successfully. The general 
approach for carboxyl protection is esterification. 
 
Methyl ester (-OMe) and Ethyl ester (-OEt). These esters are readily available through 
esterification, that is, by the introduction of HCl into an alcoholic suspension of the 
amino acid (Curtius and Goebel, 1888) or the addition of the amino acid to a cold 
mixture of thionylchloride and methanol or alcohol (Brenner and Huber, 1953). 
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Generally, methyl and ethyl esters are good blocking groups, because they can be 
cleaved easily by alkaline hydrolysis.  
 
tert. Butyl ester (-OBut). The tert-butyl ester is prepared by the addition of isobutene 
to the carboxyl group (Roeske 1959) or transesterification of carboxylic acid esters 
with tert-butyl acetate (Taschner et al., 1961). It is generally resistant against the 
attack of a nucleophile and also resistant to base catalyzed hydrolysis and weak acids. 
However, the tert-butyl group is removable with moderately strong acids, such as 
diluted solutions of HCl or trifluoroacetic acid. 
 
(2) The second step 
Formation of an amide bond between two amino acids is an energy-requiring reaction. 
In order to avoid high temperature to form a peptide bond, either the carboxyl or the 
amino group must be activated. So far, no practical activation of the amino group has 
been found. The usual approach is activation of the carboxyl group, that is, the 
hydroxyl group of the carboxyl group is replaced by an electron withdrawing 
substituent (X). The X group can enhance the polarization of carbonyl group and 
thereby the electrophilicity of its carbon atom. Thus, the nucleophilic attack by the 
amino group is greatly enhanced. 
 
(3) The third step 
The peptide bond is formed by coupling the carboxyl component and the amino 
component via an α amide linkage. 
 
The practical coupling methods are specified below. 
Azide method. The activation in the form of acid azides (Curtius 1902) remains even 
today an important and practical approach for the synthesis of peptides. Nitrous acid, 
diphenylphosphorylazide, alkyl nitrites etc. can be used for activation. The azide 
process remains one of the truly valuable assets of peptide chemists, mainly because  
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in most cases coupling via azides is accompanied with only negligible racemization. It 
is a valuable tool for fragment coupling. 
 
Mixed anhydride method. To use the symmetric anhydride of a peptide or a 
N-protected amino acid would be wasteful of that component, since only half of it 
would be exploited for peptide bond formation. However, certain unsymmetrical 
anhydrides, which react with amino components only at the carbonyl of the 
N-protected aminoacyl component, are used instead (Chantrenne, 1947). For peptide 
synthesis, mixed anhydrides of the carboxyl component with ethyl- or 
isobutylcarbonic acid are employed (Vaughan, 1951). 
  
Carbodiimide method. This method was introduced by Sheehan and Hess (1955). The 
coupling reagent, dicyclohexylcarbodiimide (DCC) is added to the mixture of the 
carboxyl component and the amino component. Thus, activation and coupling proceed 
concurrently. Amines also react with carbodiimide but the rate of this reaction is 
negligible, when compared with the rapid rate observed in the addition of carboxylic 
acids to one of the double bonds of a carbodiimide. Addition of carboxylic acid to 
carbodiimide results in the formation of O-acyl isoureas as an intermediate. The N=C 
group in O-acyl-isoureas provides activation which leads to coupling. The insoluble 
by-product, N, N’-dicyclohexylurea (DCU) formed in this reaction can be removed 
easily by filtration. In some cases, N-acyl urea as a by-product and racemization arise. 
Both racemization and N-acyl urea formation can be suppressed to some extent by the 
addition of auxiliary nucleophiles such as 1-hydroxybenzotriazole (HOBt) proposed 
by König and Geiger (1970). 
 
Active ester method. The carboxyl group is activated by the formation of an active 
ester in which an electron withdrawing group is present. The exclusive application of 
p-nitrophenyl esters for the synthesis of oxytocin (Bodanszky and du Vigneaud, 1959) 
demonstrates that active esters are particularly well suited for the stepwise elongation 
of a peptide chain by the addition of single amino acid residues. 
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(4) The fourth step 
After the synthesis is complete, the protecting groups must be totally removed, or 
selectively cleaved, if the synthesis is to be continued. 
 
In the chemical peptide systhesis, attention should be paid to how to assemble the 
peptide chain. Stepwise synthesis by repeated couplings at the carboxyl end of a 
growing peptide chain (N→C strategy) is impractical, because racemization might 
occur when the carboxyl group is activated and diketopiperazines might be formed. 
Fragment condensation can be adopted to avoid racemization only by choosing 
fragments to end in carboxyl-terminal glycine or proline. The most practical and 
useful way is the stepwise chain elongation from the C-terminus (C→N strategy).  
 
1.1.2 Classical peptide synthesis 
 
Both reacting components are mixed in homogenous solution. After each coupling 
step, the purification of the product is necessary, generally through crystallization or 
chromatographic methods.  
 
1.1.3 Solid phase peptide synthesis 
 
This method was introduced by Merrifield (1963). The basic plan is illustrated in 
Scheme 1.2. An amino acid with protected amino group is bound covalently to a 
synthetic polymer that bears reactive groups (X) (e.g. chloromethylated polystyrene).  
Peptide bond formations are carried out by repeating deprotection and coupling step. 
The peptide of the desired sequence is assembled on the polymer support. Finally, the 
peptide is cleaved from the support with the appropriate reagent.  
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Scheme 1.2 Reaction scheme of the solid phase peptide synthesis. Y, α-amine 
protecting group; X, reactive group; P, polymer. 
 
The essential advantage of using a solid support is that all the laborious purifications 
at intermediate steps in the synthesis are eliminated. Only filtration and washing 
procedures are necessary and automatization is easy. However, one of the major 
disadvantages of the solid phase synthesis is the occurrence of failure and truncated 
sequences, if the yield of every coupling step is less than 100% (Bayer et al., 1970). 
 
 
 
 
 
X 
+ DCC 
Deprotection Coupling 
Loading the amino acid 
Cleavage 
Peptide 
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1.2 Enzymatic peptide synthesis 
During the chemical peptide synthesis, the limitations arise mainly from the many 
possible side reactions (Bodanszky et al., 1979; Bodanszky and Martinez, 1981). 
Racemization has been a major problem in the chemical peptide synthesis throughout 
its history (Gross and Meienhofer, 1979). To circumvent these problems, an 
increasing number of peptide syntheses are conducted under the catalysis of enzymes 
(Jakubke et al., 1985; Bodanszky, 1993; Isowa et al., 1979; Jakubke et al., 1996). 
 
1.2.1 Enzymes 
In order to achieve the high reaction rates observed in living organisms, enzymes are 
required to lower the activation energy of the reaction. Some enzymes are purely 
proteins. In other cases, the functional enzyme consists of two parts, collectively 
called holoenzyme, an apoenzyme (the protein portion) and a cofactor. Depending on 
the enzyme, the cofactor may be an ion of a metal such as copper, iron, zinc or an 
organic molecule needed to assist the reaction in some particular way. The region of 
the enzyme, to which the substrate binds, is known as the enzyme’s active site. The 
topology of the region provides the basis for the enzyme’s chemical specificity. On 
the basis of the catalyzed reactions, enzymes can be classified into oxidoreductases, 
transferases, hydrolases, lyases, isomerases and ligases. Hydrolases have been the 
subject of more intensive study than any other. 
 
(1) Proteases 
A sort of hydrolases, are those enzymes which cleave peptides within their chain into 
smaller peptide chains (endoproteases) or hydrolyze peptides from the end to release 
single amino acids at each reaction cycle (exoproteases). The reversal of the 
proteolytic cleavage of the peptide bond by proteases leads to the enzymatic peptide 
synthesis. The shorthand notation of the specificity of protease, proposed by 
Schechter and Berger is represented in Scheme 1.3. The peptide substrate is named as 
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P or P’ on the basis of the splitting site of the peptide. Similarly, the active site of the 
protease is named as S or S’. The counting begins at the splitting site with P in 
direction to the amino end and with P’ in direction to the carboxyl end of the peptide.  
 
Scheme 1.3 Schematic representation of substrate-protease interactions (Schechter 
and Berger, 1967). 
 
With respect to the catalysis mechanism four main types of endoproteinases are 
differentiated: 
 
Serin proteases (e.g. Trypsin, Chymotrypsin, Elastase). They are characterized by a 
highly reactive serine residue in the active site. In the covalent substrate enzyme 
complex, an acyl ester is formed between the carboxylic acid of the bond being split 
and the serin hydroxyl function. 
 
α-Chymotrypsin. The key amino acids at the active site of chymotrypsin constitute a 
“charge relay system” comprising the side-chains of Asp102, His57 and Ser195 (Blow, 
1976). It hydrolyzes amides and esters as well as peptides, and shows a marked 
preference for links involving aromatic amino acid residues, such as phenylalanine, 
tyrosine or tryptophan (P1 site) (Bergmann and Fruton, 1937; 1938). The primary 
specificity of α-chymotrypsin, which is definitely associated with the P1 position, may 
be extended, if the esterase activity of the enzyme is also considered (Kloss and 
Schröder, 1964). The secondary specificity of the enzyme is expressed to a minor 
degree, so that there exists a certain preference for hydrophobic amino acid residues 
in the P2 and P1’ position of the chymotryptic substrates (Bauer, 1978).                     
Splitting site 
H2N 
S1’ S2’ S3’ S3 S2 S1 
P1’ P2’ P3’ P3 P2 P1 COOH 
Protease 
Peptide 
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Cysteine proteases (e.g. Papain, Ficin). The catalytic mechanism involves a thioester 
linkage with the carbonyl moiety of the peptide bond and the side-chain of a cysteine 
in the active-site. 
 
Papain. Papain is isolated from Carica papaya. It displays rather broad substrate 
specificity, but nevertheless, it exhibits a preference for bulky hydrophobic amino 
acid residues in the P2 position of a given substrate (Fruton, 1982). Thus, the P1 site of 
the substrate, associated with the secondary specificity of papain, can be occupied by 
variety of amino acids (Brubacher and Zaher, 1979). Due to the structural stability of 
papain over a wide pH range, papain-controlled peptide synthesis has been performed 
within a broad pH spectrum, which ranges from 4.7 (Milne et al., 1957) to 9.5 (Mitin 
et al., 1984). 
 
Acid proteases (e.g. Pepsin, Chymosin). The active site of acid proteases relies on 
two acidic aspartate amino acids. The acid proteases have the pH optimum in the low 
acid range. 
 
Pepsin. Pepsin found in the gastric juice, is the best known member of the family of 
so called ‘acid proteases’. Since the ß–carboxylate functions of two aspartic acid 
residues (Asp32 and Asp215) are involved in its catalytic mechanism, pepsin is 
designated as an aspartate protease and exhibits a pH optimum ranging from 2 to 3. 
Pepsin elicits a striking preference for those substrates whose P1 and P1’ position are 
occupied by a phenylalanine and an aromatic amino acid residue, respectively (Fruton, 
1970).  
 
Metalloproteases (e.g. Thermolysin). They possess metal ions in the active centre. An 
example is the thermolysin, which is mainly used in thermodynamically controlled 
reactions. 
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Thermolysin. The neutral metalloprotease, isolated from Bacillus thermoproteolyticus 
has frequently been used in enzymatic peptide synthesis. The enzyme binds one zinc 
ion which is essential for catalytic activity and four calcium ions which are required 
for its thermostability. Thermolysin exhibits a strong preference for peptide bonds, in 
which P1’ is a bulky hydrophobic amino acid residue except in the case of tryptophan. 
Thus, thermolysin represents a rare case, where the primary specificity of a protease is 
predominantly determined by structural features of the P1’ site of the substrates. 
Because of its stability at elevated temperature, the reactions can be catalyzed at 
higher temperature with increased solubility of the educts. 
 
(2) Amidases 
One of the sub-groups of hydrolases comprises a number of enzymes hydrolysing 
–CO-NH- links which are not concerned with protein breakdown. 
 
Penicillin G Amidase (PGA). The enzyme from Escherichia coli cleaves not only the 
phenylacetyl group of benzylpenicillin (Penicillin G), but also a variety of substituted 
and unsubstituted phenylacetamides that are not related to benzylpencillin (Margolin 
et al. 1980). The S1-subsite specificity of PGA is mainly restricted to phenylacetic 
acid and its derivatives (Virden, 1990). The exploitation of the hydrolytic potential of 
amidases other than proteases for the enzymatic removal of Nα-blocking groups in 
peptide synthesis has the advantage that it does not cleave peptide bonds. In this 
connection, Widmer et al. (1981) and Brtnik (1983) suggested the use of PGA as 
catalyst for Nα-deblocking steps. 
 
1.2.2 Methods of enzyme immobilization 
Since enzymes are sometimes not stable in the presence of high concentrations of 
organic solvents or in the presence of hydrophobic interfaces of nonmiscible solvents 
(Kasche et al., 1987), immobilization can be used to reduce enzyme denaturation. 
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Because immobilized enzyme molecules are not able to autolyze and aggregate due to 
full dispersion, immobilized enzymes show better stability than that of the free 
enzymes (Klibanov, 1979; Capellas et al., 1996a; 1996b). 
 
Besides the higher stability, the immobilisates have many other advantages, e.g. the 
reaction can be performed continuously in a reactor and controlled easily (Eckstein 
and Renner, 1995). Repeated use of the immobilisates might be important from the 
view of economy, especially in industrial processes. The immobilized enzymes can be 
easily and completely separated from the reaction system and do not contaminate the 
synthesized peptides, which is of importance in case of pharmaceutical use of 
peptides. The immobilized enzyme can be recovered by a simple filtration step. 
  
Immobilization methods are often classified as follows by the type of the chemical 
reaction used for binding (Kennedy and Melo, 1990). 
 
(1) Inclusion  
Inclusion into membranes: By this technique the enzyme is retained within a 
membrane such as a hollow fibre or microcapsule, so-called “encapsulation”. 
 
Incorporation into polymeric networks: The enzyme becomes entrapped in a fine 
polymeric network. The mesh width must be narrow enough to prevent movement of 
the enzyme out of the net, but large enough to allow free diffusion of substrates and 
products. 
 
(2) Non-covalent binding 
Adsorptive or ionic binding onto carrier materials: It is the simplest method of 
immobilization and very useful in non-aqueous system, in which desorption can be 
neglected owing to the low solubility of enzymes in these solvents. Conventional 
ion-exchange materials like diethylaminoethyl (DAEA) or carboxymethyl (CM) 
cellulose can be used as carriers; likewise, celite, calcium phosphate or Bio-Gel P-2 as 
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adsorption materials. 
 
(3) Covalent binding 
Cross-linking of enzymes: This covalent cross-linking reaction of enzymes can be 
achieved in the presence of bifunctionally cross-linking reagents, e.g. glutaraldehyde.  
 
Binding onto modified carrier materials: Covalent fixation of enzymes to solid 
supports is the most important immobilization method. This method enables enzymes 
binding preferentially onto the outer shell of the modified carrier materials with 
preselected properties (Horvath and Engasser, 1973; Carleysmith et al., 1980).  
 
Besides these, combined methods of immobilization have been described, namely, 
croos-linking following entrapment into gel or encapsulation, covalent entrapment 
into polymeric gels, etc.  
 
1.2.3 Advantages of enzymatic peptide synthesis 
The most obvious advantage of enzymatic synthesis results from one of the most 
impressive biological phenomena, namely, the pronounced capacity of an enzyme to 
catalyze chemical reactions with an otherwise unattainable specificity. One can 
distinguish between three levels of specificity, each of which individually contributes 
to the merits of the enzymatic peptide synthesis. 
 
(1) Structural specificity  
Structural specificity enables the proteases to select a substrate with distinct structural 
feature. 
 
(2) Regiospecificity 
The proteases are only associated with the α-carboxyl and the α-amino group of the 
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sensitive peptide bonds. Therefore, in a protease catalyzed reaction, generally the side 
chains and other functional groups have not to be protected in contrast to the chemical 
peptide synthesis. 
 
(3) Stereospecificity 
Proteases usually demonstrate an absolute preference for the L-enantiomeric form of 
an amino acid residue. Hence, the enzymatically catalyzed peptide bond formation 
results in an optically pure product, even if the starting material might have been 
contaminated with some D-enantiomer.  
 
In addition, enzymatic peptide synthesis can be achieved under mild conditions with 
commercially available proteases which are easy to handle and, due to their 
application in catalytic amounts only, the costs are mostly insignificantly higher in 
comparison with chemical coupling reagents. By avoiding hazardous chemicals and 
less critical reaction steps, this method is a good example of green chemistry. A very 
good example is the synthesis of aspartame on a large scale in industry, starting from 
L-Cbo-Asp-OH and D, L-Phe-OMe (Isowa et al., 1979). 
1.2.4 Methods of enzymatic peptide synthesis 
According to the type of the carboxyl component used, the methods of 
enzyme-catalysed peptide bond formation generally can be classified into two basic 
strategies: the thermodynamic and the kinetic approach. 
 
1.2.4.1 Thermodynamically controlled peptide synthesis 
 
In the thermodynamic approach, this component has a free carboxyl terminus, and the 
peptide bond formation occurs under thermodynamic control, which is a direct 
reversion of the protein hydrolysis, according to Scheme 1.4.  
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Scheme 1.4 Thermodynamically controlled peptide bond formation. R = acyl residue 
of the carboxy component; R1 = residue of the amino component; x = 
relative concentration (%); t = time. 
 
It has to be noticed that only non-ionized substrates (amino acids or peptides) 
participate in the peptide bond formation (Linderstrom–Lang (1962) and Carpenter 
(1960)). Thus, the predominant contribution to the energetic barrier to proteosynthesis 
is accounted for by ionization-neutralization effects. There are two ways to shift 
equilibrium towards the desired peptide coupling:  
 
(1) Shift of ionic equilibria  
The main obstacle to peptide bond synthesis, which comes in the form of the energy 
required for the proton transfer, depends crucially on the ionization equilibria of the 
reactants. An increase of the pK1 value and/or a decrease of the pK2 value of a given 
pair of educts, will reduce the energy consumption of the proton transfer and will, as a 
result, cause the equilibrium shift in favour of peptide synthesis. 
  
Cancelling the zwitterionic character of the reactants. The highly endergonic 
characters of the proton transfer can be accounted for by the strong acidity and 
basicity of the α carboxyl and α amino groups of the reactants which in turn, can be 
attributed to the zwitterionic nature of free amino acids and peptides. Consequently, a 
R-CO-NH-R1 
t 
R-COOH 
x 
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favourable pK shift of the ionogenic groups may be achieved by curtailing the 
zwitterionic character of the respective educts. This can be readily done by the 
introduction of α amino and α carboxyl protecting groups, a procedure which is 
routinely used during chemical peptide synthesis. 
 
Effects of organic co-solvents. Another technique to shift ionic equilibria in favour of 
peptide synthesis is to add organic solvents to the reaction mixture. By lowering the 
dielectric constant of the reaction medium, the organic co-solvent diminishes the 
hydration of ionic groups. This effect predominantly affects the pK value of those 
groups whose ionization represents a separation of charge (Michaelis and Mizutani, 
1925), most notably carboxyl functions. Thus, the acidity of the α carboxyl group and 
to a lesser extent, the basicity of the α amino group can be reduced (Mizutani, 1925; 
Homandberg et al., 1978). 
 
Variation of temperature and pH. Ionic equilibria can also be perturbated in favour of 
peptide synthesis by elevation of the reaction temperature. The degree of ionization of 
the α-amino groups of the amino acids varies significantly with temperature (pK2 
value decrease with increasing temperature) whereas that of the α-carboxyl function 
depends only slightly on temperature. The ionization properties are also influenced by 
the hydrogen ion concentration of the reaction medium. However, any pH variation is 
a double-edged sword, since any favourable shift of the ionic equilibrium of one educt 
is accompanied by an unfavourable shift of the ionic equilibrium of the other educt.   
 
Influence of the chain length of the reactants. The acidity and the basicity of a 
peptide decrease with increasing chain length. Hence, the energy required for the 
proton transfer will also decrease and the prospects of peptide synthesis will generally 
improve with growing chain legth of the reactants.  
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(2) Shift of chemical equilibria  
Solubility-controlled synthesis. This technique is based on the removal of the newly 
generated products from equilibrium by precipitation (Bergmann and Fraenkel, 1938; 
Bergmann and Fruton, 1938)) or selective extraction in a biphasic system (Basso et al., 
2000; Semenov et al., 1981; Martinek et al., 1981; Martinek and Semenov, 1981).  
 
Molecular traps. A synthesized peptide is noncovalently bound (trapped) by another 
peptide or protein to form a stable complex. Any substance capable of forming an 
intra or intermolecular complex with the reaction product, but not with the educts, 
may act as a scavenger (Chaiken 1981). 
 
Effects of concentration. According to the law of mass action, the unfavourable 
equilibrium can be shifted towards synthesis by the means of the highest possible 
concentrations of the educts, especially of the amino component or by the means of 
using organic co-solvents to reduce the water concentration (Calvet et al., 1996) 
 
Temperature-dependent equilibrium shifts. The endothermic process of peptide bond 
formation (Borsook, 1953) will be enhanced with rising temperature, as goverened by 
the Le Chatelier’s principle. 
 
1.2.4.2 Kinetically controlled peptide synthesis 
  
In the kinetic approach the carboxyl component is employed in an activated form, 
mainly as an ester derivative, and the synthesis occurs under kinetic control. The 
rapidly formed acyl enzyme intermediate can transfer the acyl moiety either in an 
aminolysis reaction to the added nuclophilic amino component forming the desired 
peptide product (R-CO-NHR1), or in a hydrolysis step to water (Scheme 1.5). 
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Scheme 1.5 Kinetically controlled peptide bond formation. R = acyl residue of the 
carboxyl component; R1 = residue of the amino component; HE = serine 
or cysteine protease; X = ester (leaving group); x = relative 
concentration (%); t = time. 
 
The optimal peptide yield depends on both the concentration and reactivity of the 
nucleophile as well as the rate of hydrolysis of the acylenzyme. Hence, it is important 
to favour the synthesis of the peptide bond by working at high concentration of the 
nucleophile and at low water concentration to minimize the proteolytic activity. As 
shown in Scheme 1.5, the concentration of the product RCONHR1 has a maximum at 
a definite time. The reaction has to be stopped at the “kinetic” optimum. The progress 
of the reaction is permanently controlled by HPLC. 
 
R-COX 
R-CO-NH-R1 
R-COOH 
x 
t 
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The syntheses of biologically active peptides have been widely investigated because 
the market of peptides is continuously growing, especially in the food and 
pharmaceutical industries (Vivien, 2005). Cholecystokinin (CCK), a gut and brain 
peptide hormone with 33 amino acid residues, is widely distributed in the central 
nervous system and the gastrointestinal tract and shows multiple biological activity. It 
can stimulate extensively the liberation of insulin and glucagon from the Langerhans 
islets (Verspohl, 1986). Besides, it is a very important neurotransmitter as well 
(Tirassa et al., 2005). Full activity is retained in the C-terminal cholecystokinin 
octapeptide (CCK-8), which is used to treat intestinal paralysis and is also a potential 
drug candidate for the treatment of type 2 diabetes (Ahren et al., 2000), obesity 
(Volkoff et al., 2005) and epilepsy (Tirassa et al., 2005). CCK-8 has the amino acid 
sequence (CCK26-33), that is, Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 (Mutt 
and Jorpes, 1968). 
 
Many efforts have been devoted to the synthesis of CCK-8, its derivatives and 
analogues (Ondetti et al., 1970; Toth et al. 1985; Penke and Rivier, 1987). Among the 
different methods, enzymatic peptide synthesis is investigated by several groups as an 
important complement to the chemical approach. 
 
In 1982, Kullmann (1982) reported the first preparation of CCK-8 using enzymatic 
peptide bond formation as far as possible.The octapeptide was finally assembled by 
the chemical condensation of two tetrapeptide segments which have been synthesized 
through the concerted actions of several proteases of different specificity, namely by 
papain-, thermolysin- and α-chymotrypsin-catalysis. The design of the synthetic 
strategy is outlined in Scheme 2.1 and in an abbreviated form it can be described as (2 
+ 2) + 4. Boc-groups were employed as N-α protecting groups for all acyl-donors. 
The results of these preliminary studies indicated that fragments containing more than 
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four amino units were not attainable exclusively by enzymatic means. Furthermore, 
the N- and C-terminal tetrapeptides could not be coupled by either papain-, 
thermolysin-, ficin-, or bromelain-catalysis, because at least one of the tetrapeptide 
was subject to proteolytic degradation before the synthesis of the desired peptide bond 
could be completed. 
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Scheme 2.1 Synthesis of the C-terminal octapeptide amide of cholecystokinin 
(CCK-8) (Kullmann, 1982); -N2H2Ph = phenylhydrazide 
 
Sakina and his associates (1988) described another pathway to obtain CCK-8, which 
is shown in Scheme 2.2. In an abbreviated form it can be described as (2 + 3) + 3, that 
is, a pentapeptide yielded from a di- with a tripeptide is coupled to a tripeptide that 
had been previously synthesized.  
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Scheme 2.2 Synthesis of the C-terminal octapeptide amide of cholecystokinin 
(CCK-8) (Sakina et al., 1988). Np = p-Nitrophenol; Tcp = 
2,4,6-Trichlorophenol. 
 
In this synthetic procedure, both tripeptides were obtained via the chemical way. N-α 
protecting group of acyl-donors were Fmoc-, Boc- and Z-group, respectively.  
 
In the same year, an alternate synthetic route was presented by Cerovsky’s group 
(1988), as shown in Scheme 2.3. CCK-8 was synthesized by 2 + (3 +3) fragment 
condensations, where the tripeptides were coupled via the chemical way. The 
attempted enzymatically catalyzed condensation between Boc-Met-Gly-Trp-OMe and 
H-Met-Asp-Phe-NH2 with α-chymotrypsin (at pH 10), subtilisin (at pH 9) or 
proteinase K (at pH 10) were tried in an aqueous buffer containing DMF, or in 
biphasic systems or only in a mixture of organic solvents. In all cases the very rapid 
enzymatically catalyzed hydrolysis of the α-methyl ester predominated and the 
formed Boc-Met-Gly-Trp-OH did not react further, and the hexapeptide obtained only 
to the extent of 15%. Boc and Z groups were utilized to protect the α-amino groups of 
the acyl-donors. 
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Scheme 2.3 Synthesis of the C-terminal octapeptide amide of cholecystokinin 
(CCK-8) (Cerovsky et al., 1988). Pfp = Pentafluorophenol; Tcp = 
2,4,6-Trichlorophenol. 
 
Later Clapes and his co-workers performed a series of studies on enzymatic synthesis 
of fragments of CCK-8, such as dipeptides, the C-terminal tripeptide and the 
C-terminal pentapeptide. In the synthesis of dipeptide fragments, Z-, Boc- and 
Fmoc-group as N-α protecting groups were tested, N-α protected amino acid allyl, 
carboxamidomethyl, and methyl ester derivatives were assayed as acyl donors in 
kinetically controlled processes, and C-α amides and esters were used as nucleophiles. 
It was found that generally amino acid N-α benzyloxycarbonyl, C-α 
carboxamidomethyl ester derivatives as acyl-donors gave the highest yields. When the 
added buffer solution was reduced from 4 to 1%, in chymotryptic couplings, a 
decrease in the reaction rate combined with an increase of the dipeptide yield was 
observed. In papain-catalyzed reactions, however, loss of activity was the main effect. 
The best enzymes for each dipeptide synthesis were: Papain, Asp-Tyr and Gly-Trp; 
α-chymotrypsin, Tyr-Met and Met-Gly; thermolysin, Asp-Phe and Asp-Tyr; papain 
and α-chymotrypsin, Trp-Met and Met-Asp (Calvet et al., 1996). This research group 
synthesized Z-Gly-Trp-Met-OX (X=H, Et, Cam or Al) via stepwise chain-lengthening 
starting with the N-terminal under the catalysis of enzymes, which were deposited on 
24              2 State of the art and aim of this research 
solid support materials. The obtained Z-Gly-Trp-Met-OX was condensed with the 
dipeptide H-Asp(OBut)-PheNH2 via immobilized α-chymotrypsin to obtain the 
protected pentapeptide. The free pentapeptide was achieved by deprotection. The 
influence of structures and concentration of acyl-donors and nucleophiles, reaction 
media and support materials used to adsorb enzymes, on both the product yield and 
enzymatic activity was investigated (Capellas et al., 1996a; 1996b; 1997; Ruiz et al., 
1997). A disadvantage of using the Z-protecting group in synthesizing CCK-8 was 
that CCK-8 has two methionine residues in which the sulfhydryl groups poison the 
catalyst and made the finial deprotection steps by means of catalytic hydrogenation 
rather difficult. Alternatively, the Z-group was deprotected by liquild hydrogen 
fluoride, an efficient but dangerous method and difficult to scale-up. Therefore, this 
research group changed to Phac-protecting group and finally obtained Phac-CCK-8. 
The strategy for Phac-CCK-8 synthesis is described as follows (Scheme 2.4) and in an 
abbreviated form it can be described as 3+ (3 + 2). However, it is not reported 
whether the phenylacetyl group of Phac-CCK-8 can be cleaved to afford the free 
CCK-8.  
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 Scheme 2.4 Synthesis of Phac-CCK-8 (Fite et al., 2002). 
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In summary of all above mentioned enzymatically controlled couplings, the reaction 
systems can be classified as follows: 
(1) Aqueous system 
The enzymatic coupling was conducted in water or buffer. Generally, this 
thermodynamic controlled reaction with unfavourable equilibrum can be shifted 
towards synthesis by the means of product precipitation. 
 
(2) Cosolvent system 
The enzymatic coupling steps were performed in monophasic aqueous-organic 
systems in order to induce a favorable shift of the ionic equilibra and to enhance the 
solubility of the initial reactants in the respective incubation mixtures. Water soluble 
solvents such as alcohols or dimethylformamide (DMF) can be employed. 
Nevertheless the activity of free or immobilized proteases in this medium will be 
affected by the presence of the organic solvent. 
 
(3) Biphasic systems 
This approach can be used when both acyl-donor and nucleophile are soluble in water 
and the product is mainly soluble in the organic phase. The reaction takes place in the 
aqueous phase and the enzyme can be used either free or immobilized by covalent 
attachment. This system largely prevents the enzymes from coming into unfavorable 
contacts with organic solvents which may cause denaturation of the proteases. 
However, mass transfer limitation and deactivation of proteases at the interphase are 
the major drawbacks of this reaction system. This problem can be overcome by using 
appropriate surfactants to reduce the interfacial tension (Feliu et al., 1995). 
 
(4) Low-water content system 
Proteases are active in reaction media with low water concentration. They can be 
employed either as enzyme powder or deposited onto a support (Mattiasson and 
Adlercreutz, 1991; Klibanov, 1986). The thermodynamic water activity (aw) in this 
system is directly related with the enzyme activity and it also influences the ratio 
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synthesis/hydrolysis in the kinetically controlled synthesis. Low-water content 
systems such as organic media have a wide range of applications in oligopeptide 
synthesis, because they are normally compatible with the solubility requirement of 
amino acid and peptide derivatives (Wartchow et al., 1995). 
 
The main disadvantage is drawn from the enzymatic strategies proposed by Kullmann 
(1982), Sakina et al. (1988) and Cerovsky et al. (1988) that many chemical couplings 
were used because of either poor yields or failure of the enzymatic steps. Even though 
Clapes’ group improved coupling steps and achieved all peptide bond formations via 
enzymatically controlled couplings, there remains the problem that Z-group had to be 
cleaved chemically. Another drawback is that two additional chemical reaction steps 
were necessary to obtain an OCam ester and therefore the overall yield decreased. 
Additionally the activation of the acyl-donors might cause racemization.  
 
The aim of this study is to circumvent such above-mentioned shortcomings and obtain 
a better strategy for the total enzymatic synthesis of the octapeptide (CCK26-33). 
 
During enzymatic peptide synthesis, the introduction of protecting groups is an 
essential requirement for ensuring the synthesis of well-defined peptides, for 
cancelling the zwitterionic character of the reactants and for further purpose insofar as 
it ensures a suitable solubility differential between educts and products. Therefore, in 
this work, Nα-protection will be achieved by the PGA-liable Phac-group and methyl 
ester will be applied for aspartic acid residue due to its simplest introduction and easy 
removal. 
 
Based on our experience in the enzymatic synthesis of fragments of cholecystokinin 
(14-18) in the last years, it was planned to assemble the target octapeptide via 
fragment condensation between a tripeptide and a pentapeptide, that is, 3+ 5 in an 
abbreviated form. Both of the two fragments will be prepared separately by stepwise 
coupling of successive amino units starting from N-terminal residue.  
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In order to achieve this goal, the following five major objectives were set. 
(1) Immobilization of enzymes 
The advantages of immobilized over soluble enzymes arise from their enhanced 
stability in organic solvents, ease of separation from reaction media, easy recovery 
and repeated use. In the first objective, different methods will be utilized to 
immobilize enzymes and the activity of the immobilized enzymes will be assayed. 
 
(2) Enzymatic synthesis of the N-terminal tripeptide  
(Phac-Asp(OMe)-Tyr-Met-OAl)  
The stepwise chain-elongation starting with the N-terminal residue (N→C strategy) 
will be applied for the synthesis of the tripeptide. Different synthetic pathways will be 
investigated. The influence of structures and concentrations of acyl-donors and 
nucleophiles, reaction media and carriers used to immobilize enzymes on both the 
product yield and enzymatic activity will be assayed. 
 
(3) Chemical synthesis of reference substances 
Chemical synthesis using Fmoc-protected amino acid pentaflurophenyl esters as acyl 
donors via the C→N strategy will be carried out to obtain the C-terminal 
pentapeptides Gly-Trp-Met-Asp(OMe)-Phe-NH2 and Gly-Trp-Met-Asp-Phe-NH2 
(CCK-5) as the reference substances for the following enzymatic synthesis of the 
C-terminal pentapeptides. Other Phac-protected peptides will be prepared according 
to the carbodiimide method. 
 
(4) Enzymatic synthesis of the C-terminal pentapeptides 
The pentapeptides will be enzymatically synthesized stepwise from the N-terminus 
(N→C strategy). Different synthetic routes will be tested. The influence of structures 
and concentrations of acyl-donors and nucleophiles, reaction media and carriers used 
to immobilize enzymes on both the product yield and enzymatic activity will be 
investigated. 
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(5) Synthesis of the octapeptide (Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2) 
This objective will emphasize on the fragment condensation between the N-terminal 
tripeptide and the C-terminal pentapeptide. 
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3 Results and discussion  
3.1 Enzyme immobilization 
3.1.1 Immobilization of the enzymes 
In this work, immobilized papain, immobilized α-chymotrypsin and immobilized 
thermolysin on different carriers were prepared as follows.  
(1) Depositing on Celite-545 or Bio-Gel P-2 
The enzyme is deposited on the solid support via physical effect.  
 
(2) Covalent binding to carrier 
Derivatization of the VA-Hydroxy-Biosynth: The polymer VA-Hydroxy-Biosynth is a 
vinyl acetate resin containing hydroxyl groups. By refluxing the 
VA-Hydroxy-Biosynth with epichlorohydrin (Burg et al., 1988), the epoxidized 
polymer (VA-Epoxy) is formed (see Scheme 3.1). The Epoxy-polymer reacted with 
equal amounts (by weight) of 6-aminohexanoic acid (at pH 10 for 48 h), the 
carboxy-polymer (VA-Carboxy) was obtained (Eckstein, 1991) (see Scheme 3.2).  
 
Covalent binding to VA-Epoxy: The amino group of enzyme attacks the epoxy group 
of VA-Epoxy and forms covalent binding to the polymer (Scheme 3.1). 
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Scheme 3.1 Epoxidation of VA-Hydroxy-Biosynth and immobilization of the enzyme. 
 
Covalent binding to VA-Carboxy: The amino group of enzyme attacks the carboxyl 
group of VA-Carboxy and forms covalent binding to the polymer (Scheme 3.2). 
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Scheme 3.2 Derivatization of the VA-Hydroxy-Biosynth and immobilization of the  
enzyme. 
 
Covalent binding to Eupergit C: Eupergit C is an epoxydised acryl resin, which is 
copolymerized from methacrylamide, N, N’–methylen-bis- (methacrylamide) and /or 
allylglycidylether. The epoxy group as a functional group of the polymer can react  
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with the amino group of enzyme and immobilize the enzyme via covalent binding 
(Scheme 3.3). 
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Scheme 3.3 Immobilization of the enzyme on Eupergit C via covalent binding 
 
Covalent binding to Polygosil60-10NH2: Polygosil60-10NH2 is an aminosilica gel. 
This modification of the carrier with glutardialdehyde was carried out according to 
Cramer and Horvath (1989). The enzyme is immobilized via an amino group on the 
activated carrier as a Schiff’s base (Scheme 3.4). 
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Scheme 3.4 Modification of Polygosil60-10NH2 with glutardialdehyde and  
immobilization of enzyme. 
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3.1.2 Activity test of the immobilized enzymes 
The activities of immobilized papain, immobilized α-chymotrypsin and immobilized 
thermolysin on different carriers have been investigated. 
 
(1) Activity test of the papain-immobilisates 
Using the above mentioned methods, papain was immobilized on VA-Epoxy 
(papain/VA-Epoxy), VA-Carboxy (papain/VA-Carboxy) and Celite-545 
(papain/Celite-545) respectively. The activity of immobilized papain is tested 
according to Koennecke et al. (1984) with Bz-Arg-OEt as substrate. The conversion 
of Bz-Arg-OEt to Bz-Arg-OH was determined with HPLC.  
 
As shown in Figure 3.1 the highest activity is observed in the case of 
papain/VA-Epoxy, which promises a great potential for papain-catalyzed peptide 
synthesis. Therefore, in this work papain/VA-Epoxy was chosen as the catalyst to 
synthesize Phac-Asp(OMe)-Tyr-OAl, Phac-Asp(OMe)-Tyr-OH, Phac-Asp-Tyr-Met- 
OAl, Phac-Gly-Trp-OMe, Phac-Gly-Trp-Met-Asp(OMe)-OMe and Phac-Gly-Trp- 
Met-Asp(OMe)-OH. 
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Figure 3.1 Hydrolysis of Bz-Arg-OEt with 50mg papain/VA-Epoxy (♦), papain/VA- 
Carboxy (■) or papain/Celite-545 (▲) in 0.5 ml 0.5 M KH2PO4 buffer 
(pH 6.0) with 0.1 mg EDTA and 0.01ml 2-mercaptoethanol. 
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Since papain is a thiolprotease and it looses its activity by oxidation, the peptide 
synthesis was performed in the presence of 2-mercaptoethanol, which can activate 
papain and maintain its activity in the presence of air. EDTA is used to complex any 
heavy metal ion, which could otherwise deactivate the –SH group of papain. 
 
The stability of papain/VA-Epoxy was also tested after its multiple uses in 
synthesizing Phac-Gly-Trp-Met-Asp(OMe)-OH in aqueous media. The results of 
activity tests (Figure 3.2) show that the stability of the immobilized papain is 
reasonably high and after one application the activity almost retains. Even after the 
third appilication, the activity decreased only to a small extend. It has to be mentioned 
that after the second application, the activity test was carried out without preactivation 
of the immobilized papain. Hence, the activity decreased a lot. As a consequence, it is 
necessary to preactivate papain prior to reusage of immobilized papain for peptide 
synthesis (Eckstein et al. 1991). After the fourth application, the catalysis of 
papain/VA-Epoxy was no more efficient enough. In conclusion, this immobilisate 
could be used at least four times in a period of several months. 
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Figure 3.2 Hydrolysis of Bz-Arg-OEt with papain/VA-Epoxy. Activity directly after 
immobilization(×), after the first application (■), after the second 
application without preactivation(▲), after the third appilication (●) and 
after the fourth application (♦). 
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(2) Activity test of the α-chymotrypsin-immobilisates 
The activity of α-chymotrypsin immobilized on Eupergit C (α-CHY/Eupergit C), on 
Celite-545 (α-CHY/Celite-545) and on Bio-Gel P-2 (α-CHY/P-2) was tested with 
Ac-Tyr-OEt as substrate, respectively. The conversion of Ac-Tyr-OEt to Ac-Tyr-OH 
was determined with HPLC.  
 
As shown in Figure 3.3, the substrate Ac-Tyr-OEt was completely hydrolyzed to 
Ac-Tyr-OH with α-CHY/Celite-545 within 10 minutes, which shows the highest 
activity. The activity of α-CHY/Eupergit C was high enough to obtain around 80% 
yield of Ac-Tyr-OH within 10 minutes, though the compete hydrolysis of the substrate 
needed more than 2 hours. However, α-CHY/P-2 had no significant activity. 
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Figure 3.3 Hydrolysis of Ac-Tyr-OEt with 20mg α-CHY/Eupergit C (♦), 
α-CHY/Celite-545 (■) or α-CHY/P-2 (▲) in 0.5 ml 0.01 M HCl-Tris 
buffer (pH 8.1). 
 
The stability of α-CHY/Eupergit C was compared to that of α-CHY/Celite-545 after 
its multiple uses in synthesizing Phac-Gly-Trp-Met-OEt in the solvent free system 
(Figure 3.4). The activity test results show that the stability of α-CHY/Eupergit C is 
reasonably high and after two applications no significant change in the activity was 
observed. However, α-CHY/Celite-545 lost its activity dramatically. One reason 
might be that the α-chymotrypsin is only deposited on Celite-545 and is adsorbed by 
weak physical effects. The enzyme can be desorbed in the aqueous solution during the 
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work-up procedure. Consequently, in point of economic view and keeping enzyme’s 
contamination away from the product as well, α-CHY/Eupergit C is superior to 
α-CHY/Celite-545.     
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Figure 3.4 Hydrolysis of Ac-Tyr-OEt with immobilized α- chymotrypsin. Activity of 
α-CHY/Eupergit C directly after immobilization (×), after the first 
application (▲), after the second application (●); activity of 
α-CHY/Celite-545 directly after immobilization (■), after the first 
application (♦). 
 
(3) Activity test of the thermolysin-immobilisates 
Immobilization of thermolysin was investigated on different support materials, such 
as Eupergit C, Celite-545 and polygosil60-10NH2. The activity test of immobilized 
thermolysin was carried out with Cbo-Asp-Phe-NH2 as substrate. The conversion of 
Cbo-Asp-Phe-NH2 to Cbo-Asp-OH and Phe-NH2 was determined with HPLC.  
 
In Figure 3.5 the activities of the thermolysin-immobilisates, thermolysin on Eupergit 
C (TLN/Eupergit C), on Celite-545 (TLN/Celite-545) and on modified 
polygosil60-10NH2 (TLN/modified polygosil60-10NH2) (42mg/g) are compared. 
TLN/Celite-545 has the highest activity with more than 80% substrate hydrolyzed 
within 15 minutes. According to a previous report (Eckstein et al., 1996), the activity 
of TLN/modified polygosil60-10NH2 is higher than that of TLN/Eupergit C, if the 
activity test is carried out directly after immobilization. Here, the data shows that 
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TLN/polygosil60-10NH2 after being stored at -20oC for 7 years still has the similar 
activity as the fresh immobilized thermolysin on Eupergit C. Besides, the activity of 
TLN/Eupergit C does not decrease after being stored at -20oC for 8 years. But the 
greatest drop in activity is observed after one application of TLN/Eupergit C in the 
synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 in high concentration of 
acetonitrile with low water content. Therefore, it can be concluded that the 
immobilized thermolysin either on modified polygosil60-10NH2 or on Eupergit C is 
definitely stable when stored at low temperature but is less stable when it is in contact 
with organic solvents as is the case of TLN/Eupergit C.  
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Figure 3.5 Hydrolysis of Cbo-Asp-Phe-NH2 with 50 mg immobilized thermolysin in 
a0.5 ml 0.5 M HCl-Tris buffer (pH 8.5). Activity of TLN/Eupergit C 
directly after immobilization (♦), after the first application (■); activity of 
TLN/Eupergit C after being stored at -20oC for 8 years (▲); activity of 
TLN/modified polygosil60-10NH2 after being stored at -20oC for 7 years 
(×); activity of TLN/Celite-545 directly after immobilization (●). 
 
(4) Activity test of PGA/Eupergit C (Fluka) 
Benzylpenicillin-Na was used as the substrate for the activity test of PGA/Eupergit C. 
The conversion of benzylpenicillin to phenylacetic acid and 6-aminopenicillanic acid 
was determined with HPLC. 
 
The activity of the immobilized PGA was found effective as there was no starting 
material detected in HPLC after 30 min (Figure 3.6). 
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Figure 3.6 Hydrolysis of benzylpenicillin-Na
 
with 50 mg PGA/Eupergit C in 0.5 ml 1 
M KH2PO4 buffer (pH 7.5). 
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3.2 Enzymatic synthesis of the N-terminal tripeptide 
(Phac-Asp(OMe)-Tyr-Met-OAl) 
For the synthesis of the N-terminal tripeptide fragment of CCK-8, there was little 
knowledge about the synthetic strategy and reaction conditions (Fite et al., 2002). 
Hence, in this work, two different pathways to synthesize the derivative with protease 
catalysts were investigated. The effect of the concentration and structure of substrate, 
reaction media, the enzyme and the carrier on the tripeptide derivative synthesis were 
studied.  
 
Two strategies (Scheme 3.5; Scheme 3.6) were applied for synthesizing the tripetide 
fragment with stepwise chain-elongation from the N-terminal residue. Phac-amino 
acid or peptide esters were used as carboxyl components. The methionine derivative, 
Met-OAl, was chosen as nucleophile in the second enzymatic coupling, because the 
tripeptide fragment obtained can be used directly as acyl-donor in the next enzymatic 
coupling. Therefore, the tripeptide fragment can be easily integrated into the final 
assembly of the octapeptide (CCK26-33).  
 
In the thermodynamic approach, the unfavourable equilibrium was shifted towards 
synthesis by the means of the highest possible concentrations of the educts, especially 
of the amino component. Beyond this, in aqueous system, the equilibrium could be 
also shifted towards synthesis by the precipitation of the product. 
 
Under kinetic control several undesired side reactions can happen: the hydrolysis of 
the acyl enzyme, secondary hydrolysis of the formed peptide bond or other 
undesirable proteolytic cleavage of protease-labile bonds in the starting fragments and 
in the product, respectively. Therefore, the progress of the reaction had been 
controlled with RP-HPLC and stopped at the “kinetic” optimum. The above 
mentioned side reactions could be minimized or eliminated by optimising the leaving 
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group of the acyl donor ester, the enzyme or the medium (e.g. pH value, solvent). A 
solvent free system, where the necessary water is supplied by salt hydrates, was the 
preferred tool in optimising the reaction medium. Another option was carrying out the 
synthesis in organic solvents containing minimum amounts of water.  
 
3.2.1 The first synthetic strategy 
The first strategy to obtain the target N-terminal tripeptide fragment is outlined in 
Scheme 3.5. It includes two approaches for synthesizing Phac-Asp(OMe)-Tyr-OAl, 
which can couple with methionine allyl ester in two different reaction media under 
catalysis of different enzymes.  
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Scheme 3.5 The first strategy for synthesizing the N-terminal tripeptide fragment. 
The isolated yields of products are shown in parentheses.  
a The yield was calculated after the unreacted educts were recycled for a 
repeated conversion. 
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3.2.1.1 Enzymatic synthesis of Phac-Asp(OMe)-Tyr-OAl 
 
(1) Synthesis in low-water content system 
Since Calvet et al. (1996) pointed out that papain was the best enzyme for the peptide 
bond formation of Asp-Tyr and generally Nα-Z protected amino acid Cam esters as 
acyl-donors gave the highest yields, Phac-Asp(OMe)-OCam was prepared from 
Phac-Asp(OMe)-OH following the procedure already described (Martinez et al., 
1983). After 7 days the reaction was stopped as there was no substantial improvement 
in the conversion and afforded 64.5% isolated yield. The obtained 1.6 equivalents of 
active ester were coupled with 1 equivalent of Tyr-OAl in EtOAc containing 0.2% 
(v/v) 0.1 M borax buffer (pH 6.9) under the catalysis of papain/VA-Epoxy in a kinetic 
approach. The maximum HPLC yield (57.3%) of the dipeptide allyl ester was reached 
after 6 h and resulted in 40.1% isolated yield. However, the overall isolated yield of 
the dipeptide allyl ester was 25.9% caused by multiple synthetic steps. 
Oligomerization of the Tyr moiety occurred in this system, and 
Phac-Asp(OMe)-Tyr-Tyr-OAl was isolated as the main by-product in 9.0% yield. 
 
(2) Synthesis in aqueous system 
Phac-Asp(OMe)-OH as acyl-donor reacted with 2 equivalents of Tyr-OAl·TOS at 
40oC in water at pH 7 using thermolysin as catalyst in a 
thermodynamically-controlled peptide synthesis. The isolated yield of the dipeptide 
allyl ester was 20.3%. The result of the low yield is in accordance with the report 
(Isowa and Ichikawa, 1979) that the tyrosine residue was a poor acyl group acceptor 
in thermolysin-catalyzed synthesis due to the “aversion” of thermolysin for tyrosine 
residues in the P1’ site. 
 
In terms of the yield of Phac-Asp(OMe)-Tyr-OAl, both of the pathways were not 
efficient. 
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3.2.1.2 Enzymatic synthesis of Phac-Asp(OMe)-Tyr-Met-OAl 
 
(1) Synthesis in low-water content system 
Phac-Asp(OMe)-Tyr-OAl and 3 equivalents of Met-OAl were incubated with 
papain/VA-Epoxy in EtOAc containing 0.2% (v/v) 0.1 M borax buffer (pH 6.9). The 
kinetically controlled synthesis was monitored by RP-HPLC. The HPLC yield (43.1%) 
of the tripeptide allyl ester was reached after 3 h. Beyond this point, the product yield 
decreased because of the oligomerization of the Met moiety and hydrolysis of the 
product to Phac-Asp(OMe)-Tyr-Met-OH. After the work-up procedure, the isolated 
yield of the tripeptide fragment was 42.1%. The kinetic process of this synthesis is 
shown in Figure 3.7. 
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Figure 3.7 Kinetic process of synthesis of Phac-Asp(OMe)-Tyr-Met-OAl (■) from 
0.25 mmol Phac-Asp(OMe)-Tyr-OAl (▲) and 0.75 mmol Met-OAl in 7.5 
ml EtOAc containing 15 µl 0.1 M borax buffer (pH 6.9), 10 µl 
β-mercaptoethanol and 1 mg EDTA with 1.0 g papain/VA-Epoxy. 
 
(2) Synthesis in solvent-free system 
In 1992, Cerovsky (1992) reported a new method that protease-catalyzed peptide 
synthesis in the presence of Na2CO3 · 10 H2O, the so-called solvent-free system, was 
completed within in a few hours giving satisfactory yields of the desired peptide 
products. Later Erbeldinger et al. (2000) applied basic salts, such as KHCO3, NaHCO3 
and K2CO3 to the thermoase-catalyzed peptide synthesis. Our previous work (Lu et al., 
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2004; Xiang et al., 2004) demonstrated that immobilized enzymes could also be 
applied in this system.  
 
Here, the synthesis of Phac-Asp(OMe)-Tyr-Met-OAl was investigated in the 
solvent-free system. Phac-Asp(OMe)-Tyr-OAl reacted with 4 equivalents of 
Met-OAl · TOS in the presence of 2 equivalents of KHCO3 and 1.6 equivalents of 
Na2CO3 · 10 H2O under the catalysis of α-CHY/Celite-545. Because of very limited 
water in this system, no hydrolysis by-product Phac-Asp(OMe)-Tyr-Met-OH was 
observed in the course of the reaction. After 5 h the reaction was stopped as there was 
no substantial improvement in the conversion. The isolated yield of 
Phac-Asp(OMe)-Tyr-Met-OAl was 42.1%. The unreacted starting material 
Phac-Asp(OMe)-Tyr-OAl was recycled for a repeated conversion. This methodology 
increased the yield to 65.2%.   
 
3.2.2 The second synthetic strategy 
Scheme 3.6 shows the the second synthetic strategy for synthesizing 
Phac-Asp(OMe)-Tyr-Met-OAl, where the intermediate Phac-Asp(OMe)-Tyr-OH 
obtained from Phac-Asp(OMe)-OMe and Tyr-OMe·HCl was an acyl-donor for the 
coupling of Met-OAl to afford the tripeptide fragment. 
 
Phac-Asp(OMe)-OMe + Phac-Asp(OMe)-Tyr-OH
Papain
Tyr-OMe HCl.
Salts
 
Phac-Asp(OMe)-Tyr-OH+ Met-OAl Phac-Asp(OMe)-Tyr-Met-OAl
Thermolysin
H2O
 
 
Scheme 3.6 The second strategy for synthesizing the N-terminal tripeptide fragment. 
The isolated yields of products are shown in parentheses. 
 
 
(52.8%) 
(76.6%) 
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3.2.2.1 Enzymatic synthesis of Phac-Asp(OMe)-Tyr-OH 
 
This enzymatic coupling between Phac-Asp(OMe)-OMe and 1.5 equivalents of 
Tyr-OMe·HCl was performed in 20 equivalents of KHCO3 and 1.5 equivalents of 
Na2CO3 · 10 H2O with free papain. In this reaction, free papain catalyzed not only the 
peptide bond formation but also the hydrolysis of Phac-Asp(OMe)-Tyr-OMe to the 
corresponding free C-terminal dipeptide simultaneously. The pure dipeptide fragment 
Phac-Asp(OMe)-Tyr-OH was obtained efficiently in 76.6% isolated yield.  
 
3.2.2.2 Enzymatic synthesis of Phac-Asp(OMe)-Tyr-Met-OAl  
 
Phac-Asp(OMe)-Tyr-OH and 2 equivalents of Met-OAl were suspended in a small 
amount of water. The minimal amount of ACN was used to achieve complete solution. 
The thermolysin-catalyzed synthesis was carried out at pH 7 in a water-bath at 40oC. 
The poorly soluble product Phac-Asp(OMe)-Tyr-Met-OAl was formed in an isolated 
yield of 52.8% within half an hour. The product precipitated from the reaction system, 
which induced a favorable shift of the chemical equilibrium. 
3.2.3 Influences on the enzymatic syntheses  
Unfortunately there is no general protocol available for enzymatic peptide synthesis. 
In order to suppress the competing hydrolysis reaction, the undesired oligomerization 
and product cleavage, each coupling step has to be optimized. A series of reaction 
parameters were investigated to find the best conditions above mentioned for each 
peptide bond formation, such as optimal acyl donor, nucleophile, reaction media and 
enzyme. 
 
(1) Influence of the concentration and structure of substrate  
Substrate concentration. To shift the equilibrium of the enzyme catalyzed peptide 
bond formation, both is necessary, an excess of one reactant and the highest possible 
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concentration. In the cases of the synthesis of Phac-Asp(OMe)-Tyr-OH and 
Phac-Asp(OMe)-Tyr-Met-OAl, it is better to apply the easily available nucleophile 
(amino acid ester) in excess, which is more economic as well, because the carboxyl 
component inherits the danger of a possible “product inhibition” of the enzyme. But 
in the synthesis of Phac-Asp(OMe)-Tyr-OAl, an excess of Phac-Asp(OMe)-OCam 
with 1.6-fold molar ration to the nucleophile Tyr-OAl was applied to minimize the 
formation of the oligomer Phac-Asp(OMe)-Tyr-Tyr-OAl. 
 
Structure of acyl-donor. Capellas (Capellas et al., 1996a) reported the reactivity 
difference among carboxamidomethyl (OCam), benzyl (OBzl) and methyl (OMe) 
esters of Z-Gly-Trp in coupling with Met-OEt in organic media. It was found that the 
methyl ester was the least reactive acyl-donor with the lowest yield of product but the 
highest yield of by-products obtained. In this study, it was also observed that 
Phac-Asp(OMe)-OMe could not be coupled with Tyr-OAl with immobilized papain in 
EtOAc. As expected, the OCam ester was necessary to obtain 
Phac-Asp(OMe)-Tyr-OAl in organic media. However, in the solvent free system, 
Phac-Asp(OMe)-OMe, the methyl ester was active enough to be coupled with 
Tyr-OMe·HCl and Phac-Asp(OMe)-Tyr-OH was isolated in a good yield (76.6%). 
With this strategy not only two reaction steps for synthesizing the Cam ester, but also 
a possible racemization during this activation could be avoided. 
 
In the synthesis of the dipeptide Phac-Asp(OMe)-Tyr-OAl, the Cam ester can be 
avoided, if Phac-Asp(OMe)-OH or Phac-Asp(OH)-OH could couple with Tyr-OAl 
under the catalysis of thermolysin. The condensation between Phac-Asp(OH)-OH 
with the free β-carboxy group and Tyr-OAl·TOS with thermolysin was tried, but no 
coupling could be observed neither in aqueous nor in organic media at pH 7.0. By 
way of contrast, as mentioned earlier, the condensation between Phac-Asp(OMe)-OH, 
where the β-carboxy group is protected with a methyl group, and Tyr-OAl·TOS or 
Tyr-OAl could be achieved in water at pH 7.0 with thermolysin. The isolated yield of 
Phac-Asp(OMe)-Tyr-OAl was 20.3%. 
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As acyl-donor to the tripeptide Phac-Asp(OMe)-Tyr-Met-OAl both dipeptides 
Phac-Asp(OMe)-Tyr-OAl and Phac-Asp(OMe)-Tyr-OH were good and the yields of 
both reactions in different reaction systems with different enzymes were the same 
(42%). The yield increased to 65.2% with further conversion of the recycled unreated 
educts. 
 
Structure of nucleophile. In organic media, for Phac-Asp(OMe)-OCam, both 
Tyr-OMe and Tyr-OAl were good nucleophiles for the corresponding synthesis of 
Phac-Asp(OMe)-Tyr-OMe and Phac-Asp(OMe)-Tyr-OAl in EtOAc containing 
low-water content with papain/VA-Epoxy. The HPLC yields of the reactions were 
above 25%. However, generally, the selection of the C-α terminal protecting group 
was made taking into account its reactivity as well as the possibility that the product 
of one reaction will be the acyl-donor for the next one. As mentioned above, it has 
been already demonstrated by Capellas (Capellas et al., 1996a) that the methyl ester 
was the least reactive acyl-donor for the next coupling step. Consequently, for the 
strategy 1, Tyr-OAl was chosen as the nucleophile to afford Phac-Asp(OMe)-Tyr-OAl 
(see Scheme 3.5).  
 
In the solvent free system, however, in contrast to Tyr-OAl, Tyr-OMe was chosen as 
the nucleophile for the synthesis of Phac-Asp(OMe)-Tyr-OH. Tyr-OMe·HCl is much 
cheaper than Tyr-OAl·TOS and it also can be easily synthesized. More important is 
that the end product of the coupling reaction is the free carboxyl group, which is 
necessary for the next coupling step with thermolysin (see Scheme 3.6). 
 
The coupling reaction between Phac-Asp(OMe)-Tyr-OAl and Met-OEt, Met-OBzl or 
Met-OAl in the low water content system (EtOAc containing small amounts of buffer) 
with papain/VA-Epoxy was investigated. It was found that the product yields (HPLC 
yields 55.2%, 29.5%, 64.4%) were obtained after 3-4 h. In the solvent free system, 
using Met-OEt as the nucleophile, the HPLC yield was 11.0%, while using Met-OAl, 
it could reach 46.3%. In both systems the highest active nucleophile was Met-OAl. 
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(2) Influence of the reaction media 
Solvent plays an important role in enzymatic peptide synthesis in organic media 
(Dordick, 1989; Cassells and Halling, 1989). Previous fundamental studies by Kise et 
al., (1990; 1988) showed that both acetonitrile and ethyl acetate were the best solvents 
providing high enzymatic activities and product yields in some enzymatic dipeptide 
syntheses. 
 
However, there were no coupling reaction between Phac-Asp(OMe)-OH and 
Tyr-OAl·TOS with thermolysin/Celite 545 in acetonitrile with low buffer content. It 
succeeded with free thermolysin in water and Phac-Asp(OMe)-Tyr-OAl could be 
obtained in an isolated yield of 20.3%. The condensation between 
Phac-Asp(OMe)-OCam and Tyr-OAl with papain/VA-Epoxy in acetonitrile with low 
buffer content, the HPLC yield of Phac-Asp(OMe)-Tyr-OAl was only 14.9%, while in 
ethyl acetate with low buffer content, the HPLC yield reached 57.3% with an isolated 
yield of 40.1%. 
 
The coupling between Phac-Asp(OMe)-OCam and Tyr-OAl in EtOAc was 
investigated in 0.1 M borax buffers with three different pH values, 5.9, 6.9 and 8.2, 
respectively. As shown in Table 3.1, at the highest pH (pH 8.2) the reaction rate was 
the fastest and the HPLC yield of over-reacted byproduct was the highest, which was 
opposite to the case with the lowest pH (pH 5.9). The highest dipeptide allyl ester, the 
desired product, was obtained at pH 6.9. Interestingly, when this coupling was carried 
out at the optimal pH, namely, pH 6.9, the isolated yield of the dipeptide allyl ester 
also changed with the content of ACN in the reaction media: 33.8% (without ACN), 
40.1% (0.8% ACN) and 26.1% (7.7% ACN). The explanation therefore is that a small 
amount of ACN is needed to increase the solubility of reactants but a higher 
concentration of ACN denatures papain.  
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Table 3.1 pH effect on the synthesis of Phac-Asp(OMe)-Tyr-OAl from 
Phac-Asp(OMe)-OCam and Tyr-OAl a. 
 
Components [%]b pH Time [h] 
Product By-product 
5.9 168 24.3 7.3 
6.9 6 57.3 9.4 
8.2 3 30.1 27.1 
a
 Reactions conditions: EtOAc, containing 0.2% (v:v) 0.1 M borax buffer, 0.1% (v/v) 
β-mercaptoethanol and EDTA, 41.1 mM Tyr-OAl, 65.8mM Phac-Asp(OMe)-OCam, 
papain/VA-Epoxy.  
b The concentrations at the “kinetic” optimum were determined by HPLC; product = 
Phac-Asp(OMe)-Tyr-OAl, by-product = Phac-Asp(OMe)-Tyr-Tyr-OAl 
 
In the tripeptide synthesis, the HPLC yields of Phac-Asp(OMe)-Tyr-Met-OAl from 
Phac-Asp(OMe)-Tyr-OAl and Met-OAl in buffered ethyl acetate with 
papain/VA-Epoxy were slightly different with the pH value of the 0.1 M borax buffer: 
67.5% at pH 5.9, 64.4% at pH 6.9 and 62.9% at pH 8.0. 
 
(3) Influence of the enzyme and the carrier 
Free papain and papain/VA-Epoxy, containing the same amount of papain, were 
applied for the coupling of Phac-Asp(OMe)-OMe and Tyr-OMe·HCl in the solvent 
free system. With papain/VA-Epoxy, only Phac-Asp(OMe)-Tyr-OMe and over-reacted 
esters were formed. With free papain, however, Phac-Asp(OMe)-Tyr-OH was the 
main product, which can be used directly in the following coupling step. Using 
immobilized papain, the resulting ester has to be hydrolyzed in a second step. 
 
After having investigated many parameters in the different pathways for synthesizing 
the tripeptide fragment, the best option is the one outlined in Scheme 3.6. In respect to 
the easily available Tyr-OMe·HCl, this strategy is more economic and the overall 
yield is 45%. This is much higher than the overall yield of strategy 1 of ca. 17%. 
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3.3 Chemical synthesis of reference substances 
Reference substances are useful for the identification of the product peak during the 
monitoring of enzymatic reactions by RP-HPLC. 
 
Since it is difficult to selectively protect the phenolic hydroxyl group of the Tyr 
residue in the chemical synthesis of the aforementioned N-terminal tripeptide 
Phac-Asp(OMe)-Tyr-Met-OAl, in this work the chemical synthesis of the tripeptide 
Phac-Asp(OMe)-Tyr-Met-OAl as reference substance was not carried out. However, 
all fragments as reference substances for monitoring enzymatic synthesis of the 
C-terminal pentapeptides were obtained in chemical way and described as follows. 
 
3.3.1 Chemical synthesis of Phac-peptides  
The chemical synthesis of peptides should be carried out from the C-terminus of the 
peptide chain. Here the needed reference Phac-peptides had been synthesized via the 
N→C strategy, because all necessary amino acid derivatives had been already 
available in the laboratory. A possible racemization and formation of 
diketopiperazines, however, did not influence their use as reference substances. 
 
Equimolar amounts of HOBt and of the free C-terminus Nα-Phac carboxyl component 
were mixed with a small excess of DCC. After the activation phase, DCU was filtered 
off and the amino component was added to the solution. Attack of the amino 
component on the activated carbonyl C-atom of carboxyl component resulted in the 
formation of the peptide bond. Phac-Gly-Trp-OMe, Phac-Gly-Trp-Met-OEt, and 
Phac-Gly-Trp-Met-Asp(OMe)-OMe were prepared as reference substances 
successively in this method using Trp-OMe·HCl, Met-OEt·HCl and 
Asp(OMe)-OMe·HCl as the amino component, respectively. But the HOBt/DCC 
method was a failure in synthesizing Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2. This 
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reference substance was successfully synthesized from 
Phac-Gly-Trp-Met-Asp(OMe)-OH and 5 equivalents of Phe-NH2·HCl in DMF with a 
small excess of DCC as coupling reagent, which was added in two portions. All the 
reference substances of the Phac-peptide derivatives were characterized by FABMS.  
 
3.3.2 Chemical synthesis of the C-terminal pentapeptides 
The chemical synthesis of the C-terminal pentapeptide fragments was carried out in 
solution in analogy to the literature (Kisfaludy and Schoen, 1983). The base-labile 
9-fluorenylmethyloxycarbonyl group (Fmoc) was applied for the protection of the 
amino group in acyl-donors and the pentafluorophenyl esters as activation of the 
carboxyl group. The active ester method of chemical synthesis of the C-terminal 
pentapeptide fragments via the C→N strategy is presented in Scheme 3.7. 
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Scheme 3.7 The chemical synthesis of the C-terminal pentapeptide fragments. 
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3.3.2.1 Chemical synthesis of Fmoc-amino acides pentafluorophenyl esters  
 
Fmoc-amino acid pentafluorophenyl esters were easily obtained in high yield 
(≥87.5%) from equal molar Fmoc-amino acid and pentafluorophenol in EtOAc or a 
mixture of EtOAc and DMF with DCC as the coupling reagent. 
 
3.3.2.2 Chemical synthesis of Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
 
Z-Asp(OMe)-Phe-NH2, easily obtained from thermolysin-controlled peptide synthesis 
in 90.6% isolated yield, was hydrogenated with the Pd/C catalyst to afford 
Asp(OMe)-Phe-NH2 in quantitative yield. The free dipeptide amide was condensed 
with an excess of Fmoc-Met-OC6F5 in DMF with addition of triethylamine. The 
obtained Fmoc-Met-Asp(OMe)-Phe-NH2 was treated with 10% dimethylamine 
solution in DMF to remove the Fmoc-group. The peptide chain was elongated by 
repeating the condensation and deprotection cycle until 
Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was achieved. The isolated yields were 
around 80% in every coupling and every deprotection step. FABMS was used to 
characterize the product in every step.  
 
3.3.2.3 Deprotection of Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
 
The partially protected pentapeptide Gly-Trp-Met-Asp(OMe)-Phe-NH2 was obtained 
by cleaving the Fmoc-group with 10% dimethylamine in DMF with the isolated yield 
of 50.0%. 
 
The fully deprotected pentapeptide Gly-Trp-Met-Asp(OH)-Phe-NH2 was achieved by hydrolysis 
with 5% NaOH in H2O/actone (v/v 1:1) with the isolated yield of 25.3%.
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3.4 Enzymatic synthesis of the C-terminal pentapeptides 
One strategy to synthesize Gly-Trp-Met-Asp-Phe-NH2 (CCK-5) has been already 
published by our group (Xiang et al., 2004). In that strategy 
Gly-Trp-Met-Asp-Phe-NH2 was obtained by coupling Phac-Gly-Trp-Met-OCam and 
H-Asp(OMe)-Phe-NH2 in acetonitrile with α-chymotrypsin, immobilized on Celite 
545, followed by basic hydrolysis of the β-methyl ester, and removal of the Phac 
group with PGA. It should be mentioned, that there were two chemical reaction steps 
necessary from Phac-Gly-Trp-Met-OH to Phac-Gly-Trp-Met-OCam and another one 
for the catalytic hydrogenation of Cbo-Asp(OMe)-Phe-NH2 to obtain 
H-Asp(OMe)-Phe-NH2. 
 
In order to optimize the strategy further by avoiding the OCam ester at the tripeptide 
fragment and the catalytic hydrogenation of the Cbo-Asp(OMe)-Phe-NH2, in this 
work the stepwise elongating the peptide chain of the pentapeptide fragments from the 
amino to the carboxyl end by using immobilized enzymes except thermolysin for the 
formation of all peptide bonds is reported. Phac-Gly-OCam, Phac-Gly-Trp-OMe as 
carboxyl components and Trp-OMe, Met-OEt·HCl as the corresponding amino 
components were coupled in EtOAc with limited water content and solvent free 
conditions via the kinetic approach, respectively. Phac-Gly-Trp-Met-Asp(OMe)-OMe, 
Phac-Gly-Trp-Met- Asp(OMe)-OH and Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were 
achieved via thermodynamically-controlled coupling in EtOAc with limited water 
content, buffer and water system using Asp(OMe)-OMe, Asp(OMe)-OMe·HCl and 
Phe-NH2·HCl as nucleophiles, respectively. Considering the total enzymatic synthesis 
of CCK-8, the C-terminal pentapeptides Gly-Trp-Met-Asp(OMe)-Phe-NH2 and 
Gly-Trp-Met-Asp-Phe-NH2 (CCK-5) can be chosen to couple with the N-terminal 
tripeptide, respectively. Therefore, the obtained Phac-Gly-Trp-Met-Asp(OMe)-Phe- 
NH2 could be selectively deprotected by cleaving the Phac-group with immobilized 
PGA to give Gly-Trp-Met-Asp(OMe)-Phe-NH2. In addition, it also could be fully 
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deprotected by alkaline hydrolysis of the β-methyl ester of the aspartic acid residue 
and cleavage of the Phac-group with immobilized PGA to yield the free CCK-5. The 
synthetic steps are outlined in Scheme 3.8. 
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Scheme 3.8 The enzymatic synthesis of the C-terminal pentapeptides via the stepwise 
   N→C strategy. The isolated yields of products are shown in parentheses. 
a The yield was calculated after the unreacted educts were recycled for a 
repeated conversion. 
 
To achieve a high yield, the carboxy protected amino acid derivative was applied in 
excess for the individual elongation step. This is important, because a too high 
concentration of the carboxy fragment could lead to product inhibition. In order to 
suppress the competing hydrolysis reactions, the undesired over-reactions and product 
cleavage, a series of reaction parameters were investigated to obtain the following 
optimized condition for each peptide bond formation, such as optimal acyl donor, 
nucleophile, reaction media and enzyme.  
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3.4.1 Enzymatic synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH 
The synthesis of the dipeptide Phac-Gly-Trp-OMe was carried out in a low-water 
content system. Phac-Gly-OCam and 1.5 equivalents of Trp-OMe were incubated in 
EtOAc containing 5% (v/v) buffer with papain/VA-Epoxy. After 3 h the reaction was 
complete and the HPLC yield of Phac-Gly-Trp-OMe was 97% and the isolated yield 
was 88.4%. 
 
The dipeptide was converted to the tripeptide Phac-Gly-Trp-Met-OEt in the 
solvent-free system. The coupling of Phac-Gly-Trp-OMe and 4 equivalents of 
Met-OEt·HCl was performed in the presence of 20 equivalents of KHCO3 and 4 
equivalents of Na2CO3 · 10 H2O with α-CHY/Eupergit C. As could be seen in HPLC, 
the starting material Phac-Gly-Trp-OMe almost vanished after 2 h giving the desired 
tripeptide (70.6% HPLC yield), the by-product Phac-Gly-Trp-OH due to the 
hydrolysis of the starting material (24.7% HPLC yield), the by-product 
Phac-Gly-Trp-Met-Met-OEt due to oligomerization (3.2 % HPLC yield) and the 
tripeptide with the free carboxy group Phac-Gly-Trp-Met-OH (1.5 % HPLC yield). 
The isolated yield of Phac-Gly-Trp-Met-OEt was 65.2% 
 
For the extension of the tripeptide to the tetrapeptide 
Phac-Gly-Trp-Met-Asp(OMe)-OH, the free carboxy group of the acyl-donor was 
necessary. Quite in contrast to the general knowledge, the alkylester even the OCam 
ester is here not a useful substrate for papain. Therefore, the Phac-tripeptide ester was 
hydrolyzed with NaOH. 
 
The tetrapeptide Phac-Gly-Trp-Met-Asp(OMe)-OH was achieved by two approaches. 
In the first approach, Phac-Gly-Trp-Met-Asp(OMe)-OH was obtained in two steps 
(Meng et al., 2006). In the first step, Phac-Gly-Trp-Met-OH and 1.7 equivalents of 
Asp(OMe)-OMe were coupled under thermodynamic control in ethyl acetate with a 
low water content (2.0% by volume) and papain/VA Epoxy. After 75 h, the high 
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conversion yield of 89.1% was observed in RP-HPLC (Figure 3.8). The isolated yield 
was 79.6%.  
 
 
(a)   
                
 
                                      (b) 
  
(c) (d) 
 
Phac-Gly-Trp-Met-OH 
Phac-Gly-Trp-Met-Asp(OMe)-OMe 
Phac-Gly-Trp-Met-OH 
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Figure 3.8 HPLC-chromatograms (HPLC system 6) of the synthesis of Phac-Gly- 
Trp-Met-Asp(OMe)-OMe from Phac-Gly-Trp-Met-OH and Asp(OMe)- 
OMe in EtOAc containing 2% buffer with papain/VA-Epoxy after the 
reaction time of 0 h (a), 24 h (b), 50 h (c) and 75 h (d). 
 
In the second step, the tetrapeptide ester had to be converted to the tetrapeptide 
carboxylic acid. In this case, the hydrolysis could not be performed by alkali, because 
the β-ester of the aspartic acid residue would have been removed simultaneously. 
Therefore the hydrolysis was conducted with α-chymotrypsin. It has been known 
since 1948 that in particular α-chymotrypsin, in addition to its proteolytic potential, is 
capable of cleaving ester linkages (Kaufman et al., 1948; Schwert et al., 1948). In the 
case of aspartic- and glutamic-acid diesters, only the α-carboxyl esters were removed 
(Kloss and Schroeder, 1964). Here, the α-chymotrypsin-mediated removal of the 
α-methyl ester from the C-terminal aspartic acid residue of Phac-tetrapeptide dimethyl 
ester was performed in a cosolvent system containing HCl-Tris buffer and acetonitrile 
(27:12 v/v) at pH 7.0. The addition of acetonitrile improved the solubility of the 
Phac-tetrapeptide dimethyl ester. After 32 h, the selective hydrolysis was completed 
(Figure 3.9). The potentially α-chymotrypsin-labile, Trp-Met bond was split in around 
10%. The isolated yield of Phac-Gly-Trp-Met-Asp(OMe)-OH was 63.7%. 
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Figure 3.9 Kinetic process of the hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe 
(■) to Phac-Gly-Trp-Met-Asp(OMe)-OH (●) in HCl-Tris and ACN (27:12,  
v/v) with α-CHY/Eupergit C at pH 7.0. 
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The second approach commenced with Phac-Gly-Trp-Met-OH and 5 equivalents of 
Asp(OMe)-OMe·HCl at pH 5.9 in buffer at 37oC with papain. 
Phac-Gly-Trp-Met-Asp(OMe)-OH could be obtained in only one step taking 
advantage of the proteolytic and hydrolytic potential of papain. As shown in the 
comparison of the chromatograms (Figure 3.10), the starting material decreased and 
the product peak increased, simultaneously the peak of Phac-Gly-Trp-OH increased. 
After some time the product peak did not increase anymore, despite the fact that there 
was still a considerable amount of the starting material present. At this point the 
reaction was stopped and the starting material and product were isolated. The 
recovered starting material could be used for another conversion. In doing this the 
yield could be increased from 37.4% to 53.0%. 
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Figure 3.10 HPLC-chromatograms (HPLC system 6) of the synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-OH from Phac-Gly-Trp-Met-OH and  
Asp(OMe)-OMe·HCl in 0.2 M KH2PO4 buffer with papain/VA-Epoxy at 
pH 5.9 and 37oC after the reaction time of 0 h (a), 4 h (b), 7 h (c) and 28 h 
(d). 
 
3.4.2 Enzymatic synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
Two solvent systems were investigated for the synthesis of the pentapeptide, in 
aqueous solution at room temperature and in a low-water content system at 40oC. 
 
In water at pH 7.0 and room temperature, the condensation between Phac-Gly-Trp- 
Met-Asp(OMe)-OH and 5 equivalents of Phe-NH2·HCl was performed with 
thermolysin in a thermodynamically controlled reaction. It was observed that the 
Trp-Met bond in the starting fragment and in the product was thermolysin-labile, 
because it was cleaved by thermolysin into Phac-Gly-Trp-OH, which was converted 
to the by-product Phac-Gly-Trp-Phe-NH2 (Figure 3.11; Figure 3.12). The isolated 
yield of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was 45.2%.  
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Figure 3.11 HPLC-chromatogram (HPLC system 6) of the synthesis of Phac- 
Gly-Trp-Met-Asp(OMe)-Phe-NH2 from Phac-Gly-Trp-Met-Asp(OMe)- 
OH and Phe-NH2·HCl in H2O with thermolysin at pH 7.0 at room 
temperature after the reaction time of 8.5 h.  
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Figure 3.12 Kinetic process of the synthesis of Phac-Gly-Trp-Met-Asp(OMe)- 
Phe-NH2 (▲) and the corresponding by-product Phac-Gly-Trp-OH (●), 
Phac-Gly-Trp-Phe-NH2 (■) from 0.2 mmol Phac-Gly-Trp-Met- 
Asp(OMe)-OH (×) and 1.0 mmol Phe-NH2·HCl (♦) in 1.1 ml H2O with 
300 µg thermolysin at pH 7.0 at room temperature. 
 
The condensation between PhAc-Gly-Trp-Met-Asp(OMe)-OH and 5 equivalents of 
Phe-NH2·HCl could be also performed in ACN containing 4% HCl-Tris buffer (v/v) at 
pH 7.0 and 40oC with thermolysin. Because of the high temperature and good acivity 
Phe-NH2 
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of thermolysin at 40oC, the cleaved product Phac-Gly-Trp-OH was immediately 
converted to the by-product Phac-Gly-Trp-Phe-NH2. Therefore the concentration of 
Phac-Gly-Trp-OH was too low to be detected in HPLC. The kinetic process is shown 
in Figure 3.13. The isolated yield of Phac-Gly-Trp-Met-Asp(OMe)- Phe-NH2 was 
64.4%.  
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Figure 3.13 Kinetic process of the synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe- 
NH2 (×) and the corresponding by-product Phac-Gly-Trp-Phe-NH2 (♦) from 
0.16 mmol Phac-Gly-Trp-Met-Asp(OMe)-OH (■) and 0.78 mmol 
Phe-NH2·HCl (▲) in 4.2 ml ACN containing 4% (v/v) 0.05M HCl-Tris 
buffer with 4 mg thermolysin at pH 7.0 at 40oC. 
3.4.3 Deprotection of the Phac-pentapeptide 
The Phac-pentapeptide Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 contains two 
protecting groups: one is the β-methyl ester of the Asp residue, which could be easily 
removed by alkaline hydrolysis; the other is the Nα-Phac group, which could be split 
enzymatically by PGA/Eupergit C. 
 
The fully deprotection of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was conducted in 
two steps. In the first step, the Phac-pentapeptide with the free β-carboxyl group in 
the aspartic acid residue was achieved through hydrolysis of Phac-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2 with NaOH in acetone/water. After acidification and washing, 
Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 (Phac-CCK-5) could be obtained in the 
isolated yield of 86.8%. In the second step, the removal of the Phac-group from 
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Phac-CCK-5 with PGA/Eupergit C was carried out in water at pH 7.6 and 35oC with 
PGA/Eupergit C. After 24 h, CCK-5 was obtained in the isolated yield of 18.8%, 
which is lower than the yield of 57.4% previously reported by our group (Xiang et al. 
2004). Probably the case was caused by the different batches of PGA/Eupergit C. 
 
The selective deprotection of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was conducted 
in one step to remove the Phac-group. The cleavage of the Phac-group from 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 in the cosolvent system with PA/Eupergit C 
or PGA/Eupergit C was investigated as follows.  
 
Due to the poor solubility of the starting material Phac-Gly-Trp-Met-Asp(OMe)- 
Phe-NH2, a mixture of EtOH/ACN (1:1 v/v) containing 0.1 M Na2HPO4 buffer (pH 
8.0) was applied with PA/Eupergit C at 35oC. After 25 h, the HPLC showed that the 
β-methyl ester of Asp residue was hydrolyzed but no cleavage of Phac-group was 
observed. However, using PGA/Eupergit C instead of PA/Eupergit C in 20% EtOH in 
1 M KH2PO4 buffer (pH 7.5), the removal of Phac-group from Phac-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2 was successful (Figure 3.14). The isolated yield of 
Gly-Trp-Met-Asp(OMe)-Phe-NH2 was 24.0%. Therefore, PGA was used to remove 
the Phac-group. 
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Figure 3.14 HPLC-chromatogram (HPLC system 6) of the selective deprotection of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 to Gly-Trp-Met-Asp(OMe)-Phe- 
NH2 and Phac-OH with PGA/Eupergit C in 20% EtOH in 1 M KH2PO4 
buffer (pH 7.5) at 35°C after the reaction time of 24 h. 
 
3.4.4 Influences on the enzymatic syntheses 
The reaction conditions above mentioned were the result of optimization studies 
regarding the enzymatic activity and yield. Valuable information was provided by 
systematic studies on every coupling step. The following variables had been modified 
for these enzymatic couplings: reaction media and temperature, substrate 
concentration and structure, type of protease and support for enzyme immobilization. 
Their effects on the condensation reactions are given below. 
 
(1) Influence of substrate structure and concentration 
Structure of acyl-donor. The chemical nature of the ester moiety of the acyl-donor 
has a strong influence on enzyme activity and product yield in kinetically controlled 
synthesis (Schellenberger et al., 1991). When the reactivity of the enzyme towards the 
acyl-donor is high, the formation of by-products is greatly minimized during the 
reaction. Furthermore, the structure of the ester may influence the relative rates of 
hydrolysis and aminolysis of the acyl-enzyme complex. 
 
In organic media, it was reported that carboxamidomethyl ester (Cam) always gave 
the best results and methyl and ethyl esters had the lowest reactivity (Capellas et al, 
1996; 1997). In this work, in spite of the low reactivity of methyl and ethyl esters, 
they were the first choice in practical, due to their availability. Only Phac-Gly-OMe 
could not be coupled with Trp-OMe with immobilized papain as catalyst. As expected, 
the OCam ester was necessary and the dipeptide was isolated in good yield (91.1%).  
 
In the solvent-free system, the methyl and ethyl ester of the dipeptide were active 
enough to be coupled with Met-OEt·HCl. There was no different reactivity between 
the two dipeptide esters and both afforded the similar isolated yield of the tripeptide 
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methyl ester. This tripeptide ester obtained via the catalysis of α-CHY/Celite 545 
could be isolated in 71.4% yield. With this strategy three reaction steps could be 
avoided in comparison to the published method by Capellas et al. (1996). 
 
From kinetics of papain-catalyzed peptide synthesis, esterified acyl donors should be 
preferable to acyl donors having a free α-carboxyl group (Oka and Morihara, 1978). 
However, Phac-Gly-Trp-Met-OEt could not be coupled with Asp(OMe)-OMe·HCl or 
Asp(OMe)-OH·HCl in buffer system, cosolvent system and solvent-free system, 
respectively, neither with papain nor α-chymotrypsin. There is also no coupling 
between Phac-Gly-Trp-Met-OAl or Phac-Gly-Trp-Met-OCam and Asp(OMe)-OMe in 
EtOAc containing 2% buffer. On the contrary, Phac-Gly-Trp-Met-OH could be easily 
coupled with Asp(OMe)-OMe·HCl under the catalysis of papain either in buffer to 
yield Phac-Gly-Trp-Met-Asp(OMe)-OH (53.0% isolated yield) or in EtOAc 
containing 2% buffer to yield Phac-Gly-Trp-Met-Asp(OMe)-OMe (79.6% isolated 
yield).  
 
Two acyl-donors, Phac-Gly-Trp-Met-Asp(OMe)-OH with β-carboxyl group protected 
as β-methyl ester and Phac-Gly-Trp-Met-Asp(OH)-OH with free β-carboxyl group 
were used to couple with Phe-NH2·HCl in water with thermolysin, respectively. In the 
former coupling reaction, Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was obtained in an 
isolated yield of 51.0%. However, if the acyl donor was Phac-Gly-Trp-Met- 
Asp(OH)-OH with the free β-carboxyl group, the product Phac-Gly-Trp-Met- 
Asp(OH)-Phe-NH2 was less than 6% HPLC yield even when it reacted with a 8-fold 
excess of Phe-NH2·HCl. Simultaneously, the amounts of the by-products, 
Phac-Gly-Trp-OH and Phac-Gly-Trp-Phe-NH2 increased to more than 33%.  
 
Structure of nucleophile. The C-α group of the nucleophile is also of great 
importance for the enzymatic synthesis of oligopeptides. In the present work, 
Trp-OMe was a good nucleophile for the synthesis of Phac-Gly-Trp-OMe with a very 
good isolated yield of 91.1%, catalyzed by papain/VA-Epoxy. And the product 
Phac-Gly-Trp-OMe can be used directly without any further chemical modification in 
the next enzymatic step. 
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Met-OEt·HCl was a better nucleophile than Met-OAl·TOS to attack the carboxyl 
component Phac-Gly-Trp-OMe. In the α-CHY/Celite 545 catalyzed peptide bond 
formation, PhAc-Gly-Trp-Met-OEt was obtained in a good isolated yield of 71.4% 
within 2 hours and the by-product Phac-Gly-Trp-(Met)n-OEt, n=2, could be kept 
below 5%. Under the same reaction condition, Phac-Gly-Trp-Met-OAl was obtained 
in an isolated yield of 58.5%. 
 
The coupling of Phac-Gly-Trp-Met-OH with different nucleophiles was investigated 
in 0.2 M KH2PO4 buffer with free papain at 37oC and pH 5.9. Using 
Asp(OEt)-OEt·HCl as the nucleophile, Phac-Gly-Trp-Met-Asp(OEt)-OH was 
obtained in HPLC yield of 21.1%, while using Asp(OMe)-OMe·HCl as the 
nucleophile, Phac-Gly-Trp-Met-Asp(OMe)-OH was obtained in HPLC yield of 46.1%. 
Therefore, the OMe ester was used for protecting the Asp residues.  
 
Substrate concentration. Substrate concentartion affects both enzymatic activity and 
yield in protease catalyzed peptide synthesis. In all coupling reactions mentioned 
above, the nucleophile exceeded the acyl-donor by at least fifty pencent in molar 
ratio.  
 
The hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe with α-CHY/Eupergit C to 
obtain Phac-Gly-Trp-Met-Asp(OMe)-OH could be improved from 52.2% to 63.7% 
(isolated yield) with lowering the concentration of Phac-tetrapeptide dimethyl ester 
from 76.9 mM to 25.6 mM.  
 
(2) Influence of the reaction media and temperature 
The coupling reaction between Phac-Gly-OCam (10 mmolar) and Trp-OMe (15 
mmolar), catalyzed by papain/VA-Epoxy, was investigated in both solvents, 
acetonitrile and ethyl acetate. In this coupling step, ethyl acetate was superior (HPLC 
yield 97.0%) to acetonitrile (HPLC yield 67.0%) (Xiang et al., 2004). 
 
The condensation reaction between Phac-Gly-Trp-OMe and Met-OEt·HCl was 
studied in organic solvent systems with α -CHY/Celite 545. In this case no 
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tripeptide was found in either acetonitrile or ethyl acetate. However, using solvent 
free conditions, peptide bond formation was observed. Different inorganic salt 
systems with crystal water were investigated to optimize the pH of the reaction. Three 
systems of inorganic salts were studied and the results are shown in Figure 3.15. The 
lowest conversion rate, 23.9%, was observed with the mixture of sodium sulfate and 
sodium carbonate decahydrate. A better yield, 40.2%, could be obtained with sodium 
carbonate and its decahydrate. With 96.0% HPLC yield the system potassium 
hydrogen carbonate / sodium carbonate decahydrate was clearly superior. Applying 
the last salt system with a 4 fold excess of the nucleophile Met-OEt the tripeptide 
ethyl ester was obtained in an isolated yield of 71.4%. At a higher excess of the 
nucleophile the Met-Met formation increased considerably.  
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Figure 3.15 Effect of different inorganic salt systems Na2SO4/Na2CO3·10H2O (♦), 
Na2CO3/Na2CO3·10H2O (■), KHCO3/Na2CO3·10H2O (▲) in the 
synthesis of Phac-Gly-Trp-Met-OEt (Xiang and Eckstein, 2005). 
 
The synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OMe, via the catalysis of 
papain/VA-Epoxy in the low-water content system, was studied in EtOAc or ACN as 
the organic media. The better isolated yield (66.3%) was obtained in EtOAc system 
than that (21.7%) in the ACN system, where more hydrolysis product 
Phac-Gly-Trp-Met-Asp(OMe)-OH was observed in the HPLC chromatogram.  
 
In the biocatalytic hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe, the pH value of 
the reaction media affected the reaction rate as well as the yield (Figure 3.16). At the 
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optimal pH value of 7, the hydrolysis with free α-chymotrypsin had a maximum 
HPLC yield of 52.0%. 
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Figure 3.16 Effect of the pH on the hydrolysis of 0.05 mmol Phac-Gly-Trp-Met- 
Asp(OMe)-OMe in 0.2 ml ACN, 0.45 ml 0.05M HCl-Tris buffer and 3 µl 
Et3N with 10 mg free α-chymotrypsin (pH 5.6 (●), pH 7.0 (■), pH 8.0 
(▲)). 
 
For the one step synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH, the reaction of 
Phac-Gly-Trp-Met-OH and Asp(OMe)-OMe·HCl was investigated at different pH 
values, reaction media and temperatures. As shown in Figure 3.17, the optimal pH 
value range in the aqueous phase is 5.5 to 6.0 with the HPLC yield (33%) of 
Phac-Gly-Trp-Met-Asp(OMe)-OH.  
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Figure 3.17 Effect of the pH on the synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH 
from 0.6 mmol Phac-Gly-Trp-Met-OH and 3 mmol Asp(OMe)-OMe·HCl 
in 10 ml 0.2M KH2PO4 buffer at room temperature with 30 mg free papain 
(pH 5.0 (□), pH 5.5 (●),pH 6.0 (×), pH 6.5 (▲), pH 7.0 (■), pH 7.5 (♦)). 
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At the optimal pH different systems were applied for this reaction of 
Phac-Gly-Trp-Met-OH and Asp(OMe)-OMe·HCl at room temperature. The results are 
shown in Table 3.2. In the solvent-free system, there was no reaction. In the biphasic 
system, EtOAc and buffer (1:1 or 1:2.3, v/v), the reaction was not efficient. 
Comparing the yields in the cosolvent system to those in the aqueous system, the 
highest yield (38.6%) was obtained in the phosphate buffer with the highest possible 
concentration of educts.  
 
Table 3.2 Effect of the reaction system on the synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-OH from 0.2 mmol Phac-Gly-Trp-Met-OH and 1.0 
mmol Asp(OMe)-OMe·HCl a. 
 
Reaction System Reaction Media Time HPLC Yield 
Solvent-free 
system 
0.4 mmol KHCO3 + 0.8 mmol  
Na2CO3·10H2O 
3 d 0.0% 
0.75 ml EtOAc + 0.75 ml 0.2M KH2PO4 5 d 12.7% Biphasic system 
0.45 ml EtOAc + 1.05 ml 0.2M KH2PO4 5 d 11.3% 
0.75 ml ACN + 0.75 ml 0.2M KH2PO4 5 d 4.7% Cosolvent 
system 0.9 ml ACN + 2.1 ml 0.2M KH2PO4 3 d 28.9% 
3 ml 0.2 M KH2PO4 22.5 h 24.8% 
3 ml 0.2 M HCl-Tris 22.5 h 25.8% 
1.5 ml 0.2 M KH2PO4 8 h 38.6% 
 
Aqueous 
system 
1.5 ml 0.2 M HCl-Tris 8 h 28.1% 
a
 Reactions were carried out at room temperature in the presence of 12 µl 
β-mercaptoethanol and 1 mg EDTA. In the two-phase system, co-solvent system and 
aqueous system, the pH of the reaction was 5.9 and 200 mg of papain/VA-Epoxy were 
used. In the solvent free system, 8 mg of free papain were used. 
 
Therefore these conditions with the highest possible concentration of educts in 
phosphate buffer at pH 5.9 were used to investigate further the influence of the 
reaction temperature on the reaction of Phac-Gly-Trp-Met-OH and 
Asp(OMe)-OMe·HCl. As shown in Table 3.3, increasing the temperature, the reaction 
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rate increased as well as the side reaction. The yield could not be improved that way. 
The highest yield (38.6%) was obtained at room temperature, however, the reaction 
time 8 hours was the longest. 
 
Table 3.3 Effect of the reaction temperature on the synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-OH from 0.2 mmol Phac-Gly-Trp-Met-OH and 1.0 
mmol Asp(OMe)-OMe·HCl a. 
 
Components b [%] Temperature 
[oC] 
Time 
[h] Product By-product Unreacted Substrate 
25 8  38.6 9.3 37.9 
30 6  28.1 13.0 44.5 
37 4.3  34.5 20.8 41.9 
a
 Reactions were carried out in the presence of 1.5 ml 0.2 M KH2PO4, 12 µl 
β-mercaptoethanol, 1 mg EDTA at pH 5.9 and 200 mg papain/VA-Epoxy. 
b
 The concentrations at the optimum were determined by HPLC; product = Phac- 
Gly-Trp-Met-Asp(OMe)-OH, by-product = Phac-Gly-Trp-OH, unreacted substrate = 
Phac-Gly-Trp-Met-OH. 
 
For synthesizing Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2, the condensation of 
Phac-Gly-Trp-Met-Asp(OMe)-OH with Phe-NH2·HCl was investigated in three 
different reaction systems. In the solvent free system, the condensation reaction failed 
completely. After 22.5 h, the product HPLC yield was only 1.7% with 27.9% HPLC 
yield of Phac-Gly-Trp-OH, 9.9% HPLC yield of Phac-Gly-Trp- Phe-NH2 and 39.5% 
HPLC yield of the unreacted starting material Phac-Gly-Trp-Met-Asp(OMe)-OH. 
However, in water at reaction pH 7.0, Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 could 
be obtained in an isolated yield of 45.2%. In the low-water content system, ACN 
containing 4% (v/v) 0.05M HCl-Tris buffer at pH 7.0, 
Phac-Gly-Trp-Met-Asp(OMe)-OH could condense with Phe-NH2·HCl to give the 
product Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 in the HPLC yield from 24.9% to 
52.5% depended on the reaction termperature.  
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The effect of the reaction temperature on the synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 in the low-water content system are shown in 
Table 3.4. Increasing the reaction temperation from 25oC to 40oC, the reaction rate of 
coupling Phac-Gly-Trp-Met-Asp(OMe)-OH with Phe-NH2·HCl increased very much 
and the product yield could be improved. However, at 50oC, the reaction rate slowed 
down probably due to the fact that thermolysin lost some activity at such a high 
temperature and the optimal product yield was the lowest. Hence, this condensation 
should be carried out in the low-water content system at an optimal temperature of 
40oC. 
  
Table 3.4 Effect of the reaction temperature on the synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 a. The concentrations at the optimum are 
shown in the second line.  
 
Componentsb [%] Temperature  Time 
[h]  Product By-product 1 By-product 2 Unreacted 
Substrate 
2.5  16.6 17.6 11.3 31.6 25 oC 
24  32.5 2.5 42.1 0 
2.5  33.5 1.6 22.9 19.2 30 oC 
4  42.8 0 34.4 0 
2.5  42.7 0 15.4 19.1 40 oC 
11  52.5 0 24.3 0 
2.5  21.3 14.6 12.5 28.8 50 oC 
7  24.9 14.1 17.3 20.9 
a
 Reactions were carried out at pH 7.0 with 4 mg thermolysin, 0.78 mmol 
Phe-NH2·HCl and 0.156 mmol Phac-Gly-Trp-Met-Asp(OMe)-OH in 4.032 ml ACN 
containing 0.168 ml 0.05 M HCl-Tris buffer. 
b
 The concentrations were determined by HPLC; product = Phac-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2, by-product 1 = Phac-Gly-Trp-OH, by-product 2 = Phac-Gly- 
Trp-Phe-NH2. 
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(3) Influence of enzyme and carrier 
The character of the enzyme, the chemical nature of the carrier and its interaction with 
enzyme and /or substrate play an important role in the yield.  
 
Two α-chymotrypsin immobilisates, α-CHY/Celite 545 and α- CHY/Eupergit C, were 
used for the coupling of Phac-Gly-Trp-OMe with Met-OEt·HCl in a solvent free 
system respectively and the corresponding isolated yields of Phac-Gly-Trp-Met-OEt 
were 71.4% and 65.2%. If using Met-OAl·TOS as the nucleophile instead of 
Met-OEt·HCl in this coupling, the corresponding isolated yield of 
Phac-Gly-Trp-Met-OAl was 58.5% and 42.0%. Despite of the lower yield in the case 
of Eupergit C, this immobilisate was preferred, since the enzyme is linked covalently 
in contrast to celite, where the enzyme is only deposited and could be desorbed and 
contaminate the final peptide.  
  
In the enzymatic hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe, papain could 
cleave the α-methyl ester at pH 6.0 in 0.2 M KH2PO4 buffer to 36.2% HPLC yield 
after 4 h. In the cosolvent system, three different types of α-chymotrypsin, free 
α-chymotrypsin, α-CHY/Celite-545 and α-CHY/Eupergit C were tested in this 
selective hydrolysis. As shown in Table 3.5, α-CHY/Eupergit C has the advantage 
over free α-chymotrypsin and α-CHY/Celite-545 that it simplifies the purification 
procedure, because of the lower amount of the by-product Phac-Gly-Trp-OH.  
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Table 3.5 Effect of the type of α-chymotrypsin on the hydrolysis of 0.05 mmol 
Phac-Gly-Trp-Met-Asp(OMe)-OMe a. The concentrations at the optimum are shown 
in the second line.  
 
Componentsb [%] Catalyst Time  
[h] Product By-product Unreacted Substrate 
1  44.3 14.1 39.8 10 mg α-CHY 
5  44.7 15.4 37.7 
5  44.8 16.9 36.4 100 mg α-CHY/Celite 
545 1  45.8 14.2 39.9 
1  45.7 0 49.4 100 mg  
α-CHY/Eupergit C 5  49.2 2.8 43.0 
a Reactions were carried out at pH 7.0 in 0.6 ml ACN and 1.35 ml 0.05 M HCl-Tris 
buffer (pH 9.0) containing 10 µl Et3N. 
b
 The concentrations were determined by HPLC; product = Phac-Gly-Trp-Met- 
Asp(OMe)-OH,  by-product = Phac-Gly-Trp-OH, unreacted substrate = Phac-Gly- 
Trp-Met-Asp(OMe)-OMe. 
 
However α-chymotrypsin is not suitable in the second approach for synthesizing 
Phac-Gly-Trp-Met-Asp(OMe)-OH in one step from Phac-Gly-Trp-Met-OH and 
Asp(OMe)-OMe·HCl since there was no coupling was observed in phosphate buffer 
at reaction pH 7.3. But the cleavage of the chymotrypsin-labile bond, Trp-Met to the 
by-product Phac-Gly-Trp-OH was obtained. 
 
The condensation of Phac-Gly-Trp-Met-Asp(OMe)-OH and Phe-NH2·HCl was 
studied with free thermolysin, TLN/Eupergit C and TLN/modified Polygosil60- 
10NH2 in ACN with low-water content. The results are shown in Table 3.6. The 
highest HPLC yield of the pentapetide was observed in the reaction catalyzed by free 
thermolysin. TLN/Eupergit C was not efficient for catalyzing the coupling with 
around 25% yield of product and the highest yield of by-products. By increasing the 
amount of TLN/Eupergit C, the initial coupling rate was increased but without 
influence on the product yield. The catalytic ability of TLN/modified Polygosil60- 
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10NH2 was the lowest, even though the activity of TLN/ modified Polygosil60-10NH2 
was similar to that of TLN/Eupergit C as shown in Figure 3.5. Consquently, free 
thermolysin was the optimal enzyme for this coupling in organic media.  
 
Table 3.6 Effect of the type of thermolysin on the synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 in the low-water content system.a The 
concentrations at the optimum are shown in the second line.  
 
HPLC Yield [%] Catalyst Time 
 [h] Product By-product 
1 
By-product 
2 
Unreacted 
Substrate 
2.5  42.7 0 15.4 19.1 4 mg TLN 
11  52.5 0 24.3 0 
25  16.9 22.0 8.8 33.5 150 mg  
TLN/Eupergit C 48  24.8 22.4 16.3 17.3 
3.5  16.1 9.9 0 53.7 1 g TLN/Eupergit C 
47  25.8 29.3 9.4 14.9 
7  2.8 0 0 77.7 1 g TLN/modified  
Polygosil60-10NH2 22.5  5.0 0 0 75.3 
a
 Reactions were carried out at pH 7.0 and 40oC in 4.032 ml ACN and 0.168 ml 0.05 
M HCl-Tris buffer (pH 8.5) with 0.78 mmol Phe-NH2·HCl 0.16 mmol 
Phac-Gly-Trp-Met-Asp(OMe)-OH. 
b
 The concentrations were determined by HPLC; product = Phac-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2, by-product 1 = Phac-Gly-Trp-OH, by-product 2 = Phac-Gly- 
Trp-Phe-NH2, unreacted substrate = Phac-Gly-Trp-Met-Asp(OMe)-OH. 
 
After having investigated many parameters in different pathways for synthesizing the 
C-terminal pentapeptides, the one-step synthesis of Phac-Gly-Trp-Met-Asp(OMe)- 
OH was superior to that of two-steps including the enzymatic hydrolysis of 
Phac-Gly-Trp-Met-Asp(OMe)-OMe in terms of cheaper and less hazardous solvents, 
and higher yield as well (see Scheme 3.8).  
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Compared to the fully deprotection of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 in two 
steps, the selective deprotection of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 is 
preferred. Thereofore Gly-Trp-Met-Asp(OMe)-Phe-NH2 was used for the final 
fragment condensation to obtain the octapeptide (CCK26-33).  
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3.5 Synthesis of the octapeptide 
(Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2) 
The octapeptide (CCK26-33) was assembled via fragment condensation between the 
obtained tripeptide Phac-Asp(OMe)-Tyr-Met-OAl and pentapeptide Gly-Trp-Met- 
Asp(OMe)-Phe-NH2 in the presence of α-CHY/Eupergit C. Based on the optimal 
strategies for synthesizing the tripeptide and the pentapeptides, the strategy for the 
total enzymatic synthesis of the octapeptide (CCK26-33) is outlined in Scheme 3.9. 
This convergent synthetic strategy can be described as 3 + 5 in an abbreviated form. 
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Scheme 3.9 The strategy for the total enzymatic synthesis of the octapeptide 
(CCK26-33) 
 
The fragment coupling of the tripeptide and the pentapeptide was conducted as 
follows. Gly-Trp-Met-Asp(OMe)-Phe-NH2 was condensed with 2 equivalents of 
Phac-Asp(OMe)-Tyr-Met-OAl in ACN containg 0.5% 0.05 M HCl-Tris buffer (pH 9.0) 
and 0.5% Et3N under the catalysis of α-CHY/Eupergit C. The reaction was detected 
74                    3 Results and discussion  
by HPLC. Some new peaks were observed. The total HPLC yield of the new 
stubstances was 25.7% after 63 h (Figure 3.18).  
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Figure 3.18 HPLC-chromatograms (HPLC system 7) of the synthesis of Phac- 
Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 from Phac- 
Asp(OMe)-Tyr-Met-OAl and Gly-Trp-Met-Asp(OMe)-Phe-NH2 in ACN 
containing 0.5% 0.05 M HCl-Tris buffer (pH 9.0) and 0.5% Et3N with 
α-CHY/Eupergit C after the reaction time of 0 h (a), 63 h (b) 
 
LC-ESIMS/PIM confirmed that the coupling between the tripeptide fragment and the 
pentapeptide fragment was successful. As can be seen from the HPLC chromatogram 
of LC-ESIMS (Figure 3.19), ESIMS electronic curve (Figure 3.20) and ESIMS 
spectra, peak 1 with tR 15.253 in HPLC (44.9%) and 14.0 min in the ESIMS 
electronic curve was the product Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)- 
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Phe-NH2 (Compound 1), which was identified with the ESIMS spectrum (Figure 3.21) 
m/z 1209.6 [M+H+], m/z 1231.7 [M+Na+], C59H72N10O14S2 requires 1208.9. The 
product was obtained in a HPLC yield of 11.5%. The chemical formula for the 
product (Compound 1) is as follows: 
Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
OH NH
CH2 CO NH CH
CH2
C
C
O
OCH3
O
NH CH CO NH CH CO
CH2CH2SCH3
NH CH2 CO NH CH CO
CH2
NH CH
CH2CH2SCH3
CO NH CH
CH2 C
O
OCH3
C NH CH CONH2
OCH2 CH2
 
                     Product (Compound 1) 
 
 
Figure 3.19 HPLC chromatogram (HPLC system in LC-ESIMS) of the crude 
products in the synthesis of Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2 
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Figure 3.20 ESIMS electronic curve of the crude products in the synthesis of 
Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
 
 
Figure 3.21 ESIMS spectrum of the product Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2 (Compound 1) 
 
The second peak (Peak 2) with tR 15.675 in HPLC (55.1%) contains compound 2 with 
14.5 min in the ESIMS electronic curve and compound 3 with 14.8 min in the ESIMS 
1209.6 
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electronic curve. As shown in the ESIMS spectra (Figure 3.22 and Figure 3.23), 
compound 2 shows m/z 1177.5 [M+H+], m/z 1199.5 [M+Na+]. its molecular mass is 
then 1176, which is 32 less than the mass of the product 
Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2. Probably, one MeOH is 
released by an intramolecular nucleophilic attack in the peptide which contains the 
aspartyl residue with the side chain carboxyl group protected in the frorm of methyl 
ester according to the literature (Bodanszky, 1993b). The fragments m/z 916.4 and 
785.2 were matched to Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met+ and 
Phac-Asp(OMe)-Tyr-Met-Gly-Trp+, therefore this substance might be the compound 2 
with one succinimide ring. 
NH CH
CH2
O
O
N CH
CH2Ph
CONH2
Met-Gly-Trp-MetTyrAsp(OMe)Phac
 
Compound 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22 ESIMS spectrum of compound 2. 
 
1199.5 
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Compound 3 shows m/z 1145.5 [M+H+], m/z 1167.6 [M+Na+]. Its molecular mass is 
then 1144, which is 32 mass units less than in the case of the compound 2. It might 
release one MeOH again from the other Asp residue with β-methyl ester protecting 
group and form the compound 3 with two succinimide rings.  
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Figure 3.23 ESIMS spectrum of compound 3. 
 
In conclusion, under this reaction condition, the two fragments could be successfully 
coupled to the product Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2. 
Further investigations are needed to avoid the β-methyl aspartyl residue succinimide 
formation. Considering that the methyl ester of aspartyl residue is subject to ring 
closure, the alternative approach is to use Gly-Trp-Met-Asp(OH)-Phe-NH2 with the 
1167.6 
.  
753.3 
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free β-carboxy group in aspartyl residue to couple with the N-terminal tripeptide 
fragment. The further research on the synthesis of CCK-8 will be carried out in our 
group.  
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4 Experimental section 
4.1 Apparatus 
(1) Analytical HPLC  
Pumps: 305 and M307 (Gilson); Software: 712 HPLC system control software 
(Gilson). UV Detector: L-7400 (Merck Hitachi LaChrom), set to 260 nm; Column: 
Nucleosil C18 (Macherey-Nagel), 5µm, 100x2 mm;  
 
(2) Preparative HPLC system  
Pumps: Metering pumps Model I/Ⅲ (ConstaMetric); UV Detector: ISCO Model 
UA-6, UV/Vis detector, set to 254 nm; Column: Nucleosil, C18, 7 µm, 250×8 mm. 
 
(3) Preparative chromatography (MPLC) 
Pumps: Peristaltic pump P-1 (Pharmacia Fine Chemicals) and ProMinent electronic 
E-0803 pump; UV Detector: ISCO Model UA-5, Absorbance/Fluorescence detector, 
set to 254 nm, and Model 1132 multiplexer-expander; Fraction collector: Model-328 
(Instrumentation Specialties Company); Column: Polygosil C18 (50-60µm), 30×4 cm. 
 
(4) Size exclusion chromatography 
UV Detector: ISCO Model UA-5, set to 260 nm, Absorbance/Fluorescence detector 
and Model 1132 multiplexer-expander; Fraction collector: Model-328 
(Instrumentation Specialties Company); Column: Sephadex LH 20 (25-100 µm), 
90×4 cm. 
 
(5) LC-ESIMS  
1100 Series LC/MSD Trap (Agilent); Column: Nucleosil C18 (Macherey-Nagel), 
5µm (100Å), 250x4.6 mm. 
 
 
4 Experimental sectio                     81 
(6) FABMS 
TSQ 70 Finnigan MAT, positive ion mode 
 
(7) Centrifuge 
Universal 16 A (Hettich) 
 
(8) pH-Meter 
E 512 (Metrohm Herisau) 
 
(9) UV lamp 
Universal-UV-lamp CAMAG (Berlin) 
 
(10) Ultrasound 
Transsonic 310 (ELMA) 
 
(11) Ultra-pure water system 
Milli-Q plus 185 (Millipore) 
 
(12) Melting point apparatus 
Modell SMP-20 (Büchi) 
 
(13) Lypohilization machine 
Cryostat: Unicryo MC 2L-60oC (Uniequip); Vacuum pump: Type 109021 Chemvac 6 
DP-101 (ILMVAC)  
4.2 Materials 
(1) Amino acids and chemicals  
All L-amino acids were gifts from Degussa. Tyrosin allyl ester p-tosylate 
(Tyr-OAl·TOS) was purchased from Senn Chemicals AG. Methionine allyl ester 
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p-tosylate (Met-OAl·TOS) and Trp-OEt·HCl were from Fluka. Fmoc-Gly-OH, 
Fmoc-Trp-OH and Fmoc-Met-OH were obtained from Novabiochem, Merck. 
Pentafluorophenol was from Merck (Darmstadt, Germany). Benzyl penicillin sodium 
was obtained from Fluka. N-Acetyl-L-tyrosin ethyl ester was from Sigma. 
Bz-Arg-OEt·HCl and Z-Asp-Phe-NH2 were prepared by standard procedures in our 
laboratory. 10% Pd-C was a gift from Degussa. Absolute DMF was prepared 
according to the following procedure. 1.5L DMF, 180ml benzene and 70ml water 
were mixed and distilled under normal pressure until the temperature remained 
constant at 153oC. Then calcium hydride (10 mg) was added slowly and kept 
overnight. Then it was distilled in vacuum under nitrogen and excusion of light with 
maintaining the temperature between 60 and 100oC. HPLC grade methanol and HPLC 
grade acetonitrile were obtained from Fischer chemicals. All other chemicals used 
were of analytical grade. 
 
(2) Enzymes 
Papain (EC 3.4.22.2) from Carica papaya (water-soluble, 30000 USP-U/mg using 
casein as substrate) and α-chymotrypsin (EC 3.4.21.1) from bovine pancreas (Type II, 
3xcrystallized, lyophilized powder, 350 U/mg using N-acetyl-L-tyrosine ethyl ester 
(ATEE) as substrate) were obtained from Merck (Darmstadt, Germany). Thermolysin 
(EC 3.4.24.2) from bacillus thermoproteolyticus rokko (Protease X, lyophilized 
powder containing calcium and sodium buffer salts, 50 U/mg protein, casein assay) 
was from Sigma (St. Louis, MO, U.S.A.). Penicillin G Amidase (PGA), immobilized 
on Eupergit C (109U/g) was obtained from Fluka.  
 
(3) Carriers for immobilization of enzymes 
Celite-545 (particle size 20-45 µm) was obtained from Fluka (Buchs, Switzerland). 
Eupergit C and VA-Hydroxy-Biosynth were from Roehm Pharma (Darmstadt). 
Polygosil60-10 NH2 (particle size 10 µm) was from Macherey-Nagel. Bio-Gel P-2 
polyamide was obtained from Bio-Rad. 
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(4) Materials for chromatography 
Nucleosil C18 (5 µm) and Polygosil C18 (60-80µm) were from Macherey-Nagel 
(Düren, Germany). The HPLC columns were packed in our laboratory according to 
the high viscosity method. Silica gel plates, F254 were obtained from Merck. Sephadex 
LH 20 (25-100 µm) was from Pharmacia Fine Chemicals (Sweden). 
4.3 Methods of chromatography 
(1) Analytical HPLC 
Solvent system. Eluent A: 0.05M AcONH4 (pH 6.5), which was prepared from 2 M 
AcONH4 (pH 6.5) (filtered through 4 µ-frit) and degassed by evacuation; Eluent B: 
80% MeOH/0.05 M AcONH4, which was prepared by mixing 25 ml 2 M AcONH4 
(pH 6.5), 800 ml methanol and 175 ml water and degassed by evacuation. 
Flow rate. 0.3 ml/min.  
 
HPLC system 1. Isocratic eluent 50% B. This method was used for the activity test of 
the papain-immobilisates and PGA-Eupergit C. 
 
HPLC system 2. Isocratic eluent 40% B. This method was used for the activity test of 
the α-chymotrypsin-immobilisates. 
 
HPLC system 3. Isocratic eluent 65% B. This method was used for the activity test of 
the thermolysin-immobilisates. 
 
HPLC system 4. Gradient elution 40%B to 85%B over 10 min: 0-4.5 min, 40% B; 
4.5-7 min, 40% B to 85% B; 7-11.5 min, 85% B; 11.5-12.5 min, 85% to 35% B; 
12.5-13.5 min, 35% B; 13.5-14.5 min, 35% B to 40% B; 14.5-17.5 min, 40% B. This 
method was used during the synthesis of the N-terminal tripeptide fragment from 
amino acid derivaties. 
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HPLC system 5. Isocratic eluent 90% B. This method was used during the chemical 
synthesis of the C-terminal pentapeptides. 
 
HPLC system 6. Gradient elution 55% B to 85% B over 10 min: 0-4.5 min, 55% B; 
4.5-7 min, 55% B to 85% B; 7-11.5 min, 85% B; 11.5-12.5 min, 85% to 50% B; 
12.5-13.5 min, 50% B; 13.5-14.5 min, 50% B to 55% B; 14.5-19.5 min, 55% B. This 
method was used during the enzymatic synthesis of the C-terminal pentapeptides. 
 
HPLC system 7. Gradient elution 70% B to 90% B over 10 min: 0-4.5 min, 70% B; 
4.5-7 min, 70% B to 90% B; 7-11.5 min, 90% B; 11.5-12.5 min, 90% to 65% B; 
12.5-13.5 min, 65% B; 13.5-14.5 min, 65% B to 70% B; 14.5-22.5 min, 70% B. This 
method was used during the enzymatic synthesis of the octapeptide (CCK26-33). 
 
(2) Preparative HPLC 
Solvent system. Eluent A: 0.05 M AcONH4 (pH 6.5); Eluent B: 80% MeOH/0.05 M 
AcONH4. 
Flow rate. 3 ml/min. 
 
(3) MPLC 
Solvent system. Eluent A: 0.05 M AcONH4 (pH 6.5); Eluent B: 80% MeOH/0.05 M 
AcONH4. 
Elution. Gradient elution 30% B to 80% B. 
Flow rate. 5 ml/min. 
 
(4) Size exclusion chromatography 
Elution. MeOH 
Flow rate. 5 ml/min. 
 
(5) LC-ESIMS 
Solvent system. Eluent A: 0.1% HCOOH in H2O; Eluent B: 0.1% HCOOH in ACN. 
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HPLC System. Gradient elution 30% B to 90% B over 30 min: 0-5 min, 30% B; 5-15 
min, 30% B to 90% B; 15-30 min, 90% B.  
Flow rate. 1 ml/min 
MS condition. ESI, positive ion mode; dry temperature: 350oC; dry gas: 10.0 l/min; 
nebulizer 50.0 psi. 
 
(6) Thin layer chromatography 
TLC system 1. n-Butanol/acetic acid/water 3:1:1 (v/v/v).  
TLC system 2. Dichloromethane/methanol 7:3 (v/v) 
TLC system 3. Dichloromethane/methanol 9:1 (v/v) 
 
Spots were detected as follows: 
UV-Test. The UV active substances were detected in 254 nm. 
 
Ninhydrin reaction. 1.5 g ninhydrin and 15 ml acetic acid were mixed in 450 ml 
ethanol. The solution was sprayed on the plates and heated to 110oC. The positive 
ninhydrin substances showed the violet spots. 
 
Chlorine/Tolidine reaction. The plates were exposed to chlorine gas for about 5 
minutes. Then tolidine solution was sprayed on these plates. The tolidine solution was 
prepared by dissolving 240 mg tolidine, 2 g potassium iodide in 69 ml acetic acid and 
then the volume was brought to 1000 ml with water. The protected amino acids and 
the peptides showed a greenish yellow colour.   
4.4 Characterization of the products  
There are many ways to confirm the structure of a product. In this work, elemental 
analysis is not very useful, because the values determined by elemental analysis will 
not largely differ from peptide to peptide due to their abundant C, H, O and N 
elememts.  
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Thin layer chromatography is optimal and easy to perform. Besides detecting the UV 
active substances by TLC with the UV lamp, the UV inactive substances could be 
detected with the ninhydrin test followed by the chlorine/tolidine test.  
 
HPLC is highly useful for following the kinetic of a coupling reaction. RP-HPLC 
examination of the peptides allows rapid separation and quantitation of the 
components in a mixture. 
 
If reference substances are available, the products were compared with the properties 
of the reference samples in terms of melting point, retention time in RP-HPLC and Rf 
value in TLC. The final structure determination was made by MS analysis.  
 
In this work, the purity of the sample is determined by HPLC. If there is a single 
symmetrical peak of correct retention time, one can assume that the sample is pure. 
 
Racemization occurs either in strongly acidic or strongly basic condition and during 
the activation of the carboxyl group. In this work, enzymatic methods are used for 
coupling and consequently there is no question of optical purity as there is no danger 
of racemization. Even if the substrate is racemized to some extent, the enzymes are 
highly specific and selective to couple only the L-isomer for the next coupling steps.  
4.5 Enzyme immobilization 
(1) Derivatization of the VA-Hydroxy-Biosynth 
Preparation of VA-Epoxy. 6 g VA-Hydroxy-Biosynth in 60 ml epichlorohydrin were 
refluxed for 4 h, and then sucked and washed with acetone. The VA-Epoxy was stored 
at -20oC.  
 
Preparation of VA-Carboxy. 0.5 g VA-Epoxy and 0.5 g 6-aminohexanoic acid were 
suspended in 10 ml H2O. The pH value was adjusted by 4 M NaOH to pH10. After 
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stirring for 48 h, it was filtered and the product carboxy-polymer (VA-Carboxy) was 
washed with 1 M HCl and water successively, dried in vacuum and stored at -20oC. 
 
(2) Immobilization of papain 
Adsorbing papain on Celite-545. The solution of 60 mg papain in 30 ml water was 
mixed with 2 g Celite-545 rods. After thorough mixing for 24 h, the suspension was 
lyophilized and stored at -20oC.  
 
Immobilizing papain on VA-Epoxy. 4 g VA-Epoxy washed with water and then 1 M 
KH2PO4 buffer (pH 7.5) were suspended in 40 ml 1 M KH2PO4 buffer (pH 7.5). To 
this solution, 800 mg pain were added and mixed for 24 h. It was filtered and the 
papain/VA-Epoxy was washed with water and stored at -20oC. 
 
Immobilizing papain on VA-Carboxy. 500 mg VA-Carboxy was incubated with 333 
mg N-ethyl-N’-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) in 13 ml 
water (pH adjusted to 5) for 30 min, then 200 mg papain was added. After rotating for 
24 h, it was filtered and the papain/VA-Carboxy was completely washed with water 
and stored at -20oC. 
 
(3) Immobilization of α-chymotrypsin 
Adsorbing α-chymotrypsin on Celite-545. The solution of 100 mg α-chymotrypsin in 
15 ml water and 15 ml 0.05 M HCl-Tris buffer (pH 9.0) was mixed with 10 g 
Celite-545 rods. After thorough mixing for 24 h, the suspension was lyophilized and 
stored at -20oC.  
 
Adsorbing α-chymotrypsin on Bio-Gel P-2. A solution of α-chymotrypsin in 5 ml 
water and 5 ml 0.05M HCl-Tris buffer (pH 9.0) was mixed with 1g Bio-Gel P-2 
polyamide. After thorough mixing for 24 h, the solvent was sucked off and the 
α-CHY/P-2 was dried under vacuum overnight. 
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Immobilizing α-chymotrypsin on Eupergit C. 10 g Eupergit C washed with 1 M 
KH2PO4 buffer (pH 8.0) were added to the solution of 600 mg α-chymotrypsin in 100 
ml 1 M KH2PO4 buffer (pH 8.0). After rotating for 3 days, 100 ml 1 M NaCl were 
added to the suspension. The solvent was sucked off and the α-CHY/Eupergit C was 
washed with 0.05 M KH2PO4 buffer (pH 8.0) and stored at -20oC.   
 
(4) Immobilization of thermolysin 
Adsorbing thermolysin on Celite-545. The solution of 50 mg thermolysin in 30 ml 
water was mixed with 2 g Celite-545 rods. After thorough mixing for 24 h, the 
suspension was lyophilized and stored at -20oC.  
 
Immobilizing thermolysin on Eupergit C. 1 g Eupergit C washed with 1 M KH2PO4 
buffer (pH 7.5) were added to the solution of 45 mg thermolysin in 15 ml 1 M 
KH2PO4 buffer (pH 8.0). After rotating for 24 h, the solvent was sucked off and the 
TLN/Eupergit C was washed with 1 M KH2PO4 buffer (pH 7.5), 1 M HCl-Tris buffer 
(pH 7.5) and water successively and then stored at -20oC.   
 
Immobilizing thermolysin on Polygosil 60-10 NH2. 600 mg aminosilica gel was 
washed with water and then 0.01 M KH2PO4 buffer (pH 6.0). This silica gel was 
activated with 36 ml 6% gluardialdehyde (50% in water)/ 0.01 M KH2PO4 buffer (pH 
6.0) (that is, 4.3 ml glutardialdehyde (50% in water) and 31.7 ml 0.01 M KH2PO4 
buffer (pH 6.0)). After stirring for 30 min, the solution was sucked off and the 
activated Polygosil60-10NH2 was washed with water and then the same buffer in 
order to be equilibrated. To the solution of 25 mg thermolysin in 3.6 ml 0.01 M 
KH2PO4 buffer (pH 6.0), the activated Polygosil60-10NH2 was added and mixed for 
75 min at 4oC. After sucking the solvent off and washing with water, the filter cake 
was rotated in a 10 ml vial with 0.5 M HCl-Tris buffer for 30 min at 10oC. At the end, 
it was filtered and the TLN/modified Polygosil60-10NH2 was washed with water and 
0.01 M KH2PO4 buffer (pH 6.0), and then stored at -20oC. 
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4.6 Activity test of immobilized enzymes 
The enzyme-activity was determined as µmol conversion of test substrate per mg 
immobilized enzyme after 1 hour reaction time.  
 
(1) Papain-immobilisates 
Preactivation of papain-immobilisate. 800 mg papain-immobilisate in 8 ml 0.5 M 
KH2PO4 buffer (pH 6.0), 1mg EDTA and 12 µl mercaptoethanol were mixed for 1 h, 
then filtered. The papain-immobilisate was washed with 0.5 M KH2PO4 buffer (pH 
6.0) (3x8 ml). 
 
Activity test. To 0.5 ml test solution (300 mg Bz-Arg-OEt·HCl in 5 ml 0.5 M KH2PO4 
buffer (pH 6.0), 1 mg EDTA and 100 µl mercaptoethanol), 50 mg immobilized papain 
were added. Aliquots (10 µl) were withdrawn from the reaction mixture at different 
times from 0 min to 520 min and analyzed by HPLC with HPLC system 1. 
 
Activity of papain-immobilisates. 
Papain/Celite-545 (30mg/g): 0.65 µmol·h-1·mg-1 
Papain/VA-Epoxy (200mg/g) (fresh): 1.41 µmol·h-1·mg-1 
Papain/VA-Epoxy (200mg/g) (after the first application)): 1.26 µmol·h-1·mg-1 
Papain/VA-Epoxy (200mg/g) (after the second application without preactivation): 
0.70 µmol·h-1·mg-1 
Papain/VA-Epoxy (200mg/g) (after the third application): 1.04 µmol·h-1·mg-1 
Papain/VA-Epoxy (200mg/g) (after the fourth application): 0.61 µmol·h-1·mg-1 
Papain/VA-Carboxy (400mg/g): 0.41 µmol·h-1·mg-1 
 
(2) α-Chymotrypsin-immobilisates 
Activity test. To 0.5 ml test solution (20 mg Ac-Tyr-OEt in 2 ml 0.01 M HCl-Tris 
buffer (pH 8.1)), 20 mg immobilized α-chymotrypsin were added. Aliquots (10 µ l)  
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were withdrawn from the reaction mixture at different times from 0 min to 120 min 
and analyzed by HPLC with HPLC system 2. 
 
Activity of α-chymotrypsin-immobilisates. 
α-CHY/Celite-545 (10mg/g)(fresh): 1.00 µmol·h-1·mg-1 
α-CHY/Celite-545 (10mg/g)(after the first application): 0.29 µmol·h-1·mg-1 
α-CHY/P-2 (30mg/g): 0.43 µmol·h-1·mg-1 
α-CHY/Eupergit C (60mg/g)(fresh): 0.87 µmol·h-1·mg-1 
α-CHY/Eupergit C (60mg/g)(after the first application): 0.77 µmol·h-1·mg-1 
α-CHY/Eupergit C (60mg/g)(after the second application): 0.75 µmol·h-1·mg-1 
 
(3) Thermolysin-immobilisates 
Activity test. To 0.5 ml test solution (180 mg Cbo-Asp-Phe-NH2 in 10 ml 0.5 M 
HCl-Tris buffer (pH 8.5)), 50 mg immobilized α-chymotrypsin were added. Aliquots 
(10 µl) were withdrawn from the reaction mixture at different times from 0 min to 120 
min and analyzed by HPLC with HPLC system 3. 
 
Activity of thermolysin-immobilisates. 
TLN/Celite-545 (25mg/g): 0.39 µmol·h-1·mg-1 
TLN/Eupergit C (45mg/g) (fresh): 0.20 µmol·h-1·mg-1 
TLN/Eupergit C (45mg/g) (after the first application): 0.09 µmol·h-1·mg-1 
TLN/Eupergit C (42mg/g) (after being stored for 8 years): 0.18 µmol·h-1·mg-1 
TLN/Polygosil60-10 NH2 (42mg/g) (after being stored for 7 years): 0.19 
µmol·h-1·mg-1 
 
(4) PGA/Eupergit C 
Activity test. To the solution of 6.4 mg benzylpenicillin-Na in 0.5 ml 1 M KH2PO4 
buffer (pH 7.5) 50 mg PGA-Eupergit C were added. Aliquots (10 µl) were withdrawn 
from the reaction mixture at different times from 0 min to 35min and analyzed by 
HPLC with HPLC system 1. 
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Activity of PGA/Eupergit C. 
PGA/Eupergit C (120U/g): 0.36 µmol·h-1·mg-1 
 
4.7 Preparation of amino acid derivatives 
(1) Preparation of Phac-Gly and Phac-Asp (Mardle et al., 1968; Suyama et al., 
1965) 
To a stirred solution of 0.26 mol of amino acid in 260 ml of 2 M NaOH, 35 ml (0.26 
mol) of phenylacetylchlorid and 65 ml of 4 M NaOH were added dropwise 
simultaneously within 1 h. After 2 h, the reaction mixture was acidified with 6 M HCl 
to pH 2 in an ice-bath. The product was precipitated, filtered and recrystallized with 
methanol. The yield and analytical data are given in Table 4.1. 
 
(2) Preparation of the methyl or ethyl ester hydrochlorids of tyrosine, tryptophan, 
methionine, asparatic acid, phenylalanine and Phac-glycine (Brenner et al., 1950; 
Fles and Markovac-Prpic, 1957) 
To a stirred solution of 0.15 mol amino acid or Phac-Gly in 300 ml of absolute MeOH 
(or EtOH) cooled at -5oC, 73 ml (1 mol) of thionyl chloride were added dropwise and 
the reaction temperature was kept below 0oC. After adding two third of thionyl 
chloride, another 100 ml of MeOH was added to the reaction mixture. When all 
thionyl chloride was added, the reaction mixture was kept at room temperature 
overnight. The mixture was concentrated in vacuum and the crude product was 
dissolved in 150 ml of MeOH (or EtOH), and then the MeOH (or EtOH) was removed 
completely. For synthesizing the diester of aspartic acid, another 73 ml (1 mol) of 
thionyl chloride were added dropwise to the residue  dissolved in 200 ml of MeOH 
(or EtOH) at -5oC and the above precudure was repeated. After removing the solvent, 
of MeOH (or EtOH) (3x150 ml) added into the residue and removed in vacuo. At the 
end the residue was recrystallized in 50ml of MeOH (or EtOH) and 150 ml of diethyl  
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ether. The crystals were filtered and washed with 50 ml of diethyl ether and dried in 
vacuo. The yield and analytical data are given in Table 4.1. 
 
(3) Preparation of Asp(OBzl)-Bzl·TOS 
13.3 g (0.1 mol) of aspartic acid, 43.2 ml of benzyl alcohol, 22.8 g of 
p-toluenesulfonic acid and 300 ml of benzene were mixed and refluxed for 10 h with 
separating water by azeotropic distillation. After cooled to room temperature, the 
precipitate was filtered off and recrystallized with ether/petroleum ether (1:1 v/v). The 
yield and analytical data are given in Table 4.1. 
 
(4) Preparation of Met-OBzl·TOS  
7.46 g (0.05 mol) of methionin, 80 ml of benzyl alcohol, 9.75 g (0.051 mol) of 
p-toluenesulfonic acid monohydrate and 100 ml of benzene were mixed and refluxed 
with separating water by azeotropic distillation. Refluxing was continued for another 
2 h after no more water was produced. Then benzene and the excess of benzyl alcohol 
were distilled off under reduced pressure (bath temperature＜45oC), and the residue 
was solidified by trituration with ether. The solid was recrystallized with ethanol/ether. 
The yield and analytical data are given in Table 4.1. 
 
(5) Preparation of free amino acid esters 
To 1.4 g (5 mmol) of Na2CO3·10H2O in 20 ml of water in an ice-bath, 10 mmol of the 
hydrochloride amino acid ester were added in portions. The mixture was stirred for 15 
min at a pH above 8. It was extracted with CH2Cl2 (3x15 ml). The organic layer was 
washed with saturated NaCl, dried over anhydrous Na2SO4 and concentrated in vacuo 
at 30oC. The free amino acid ester was used immediately for the coupling reaction. 
 
(6) Preparation of Asp(OMe)-OH·HCl 
To 208 ml of absolute MeOH cooled to -10oC, 31 ml of SOCl2 and 40 g (0.3 mol) of 
aspartic acid were added. A clear solution was obtained on slowly warming to room 
temperature. After standing 25 min at room temperature, 600 ml of absolute ether 
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were added. After cooling in an ice-bath, the precipitate was filtered off and 
recrystallized with methanol/ether containing a small amount of HCl. The yield and 
analytical data are given in Table 4.1. 
 
(7) Preparation of Phe-NH2·HCl 
To a stirred, cooled to -5oC solution of 65 g (0.3 mol) of Phe-OMe·HCl in 342 ml of 
absolute MeOH, ammonia gas was passed through. The saturated solution was placed 
at room temperature overnight. Then the solvent was removed, 2 M HCl and water 
were added to the residue. After removal of the solvent, 2 M HCl and water were 
added to the residue again. The crude product was obtained after removing the solvent 
and recrystallization with EtOH. The yield and analytical data are given in Table 4.1. 
 
(8) Preparation of Phac-Asp(OMe)-OH and Z-Asp(OMe)-OH (Schwarz et al., 
1957) 
9.6 g (52.3 mmol) of Asp(OMe)-OH·HCl were dissolved in a solution of 90 ml of 
water, 12 ml of 4 M NaOH (48 mmol) and 8.7 g (103 mmol) of NaHCO3. Under 
stirring at room temperature 66.6 mmol phenylacetylchloride (or benzylchloroformate) 
was added over a 2-hour period. Then 4 M NaOH was added and the pH was kept at 8 
via a pH stat. The reaction was finished when no more NaOH was consumed. The 
mixture was extracted with ether (3x20 ml) and the ether extracts were discarded. The 
aqueous phase was acidified to pH 2.0 with concentrated HCl, and then extracted with 
EtOAc (3x50 ml). The combined EtOAc layers were washed with water (2x20 ml), 
dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was 
recrystallized with EtOAc/petroleum ether. The yield and analytical data are given in 
Table 4.1. 
  
(9) Preparation of Phac-Asp(OMe)-OMe (according to Martinez et al., 1983; 1985) 
5 g (0.02 mol) of Phac-Asp was suspended in 100 ml of absolute MeOH and cooled to 
-5oC. 5.5 ml of SOCl2 was added to the mixture over 30 min with rapid stirring. Then 
the reaction mixture was kept at room temperature for 2 h. After removal of MeOH 
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under vacuum (bath temperature＜45oC), the residue was treated twice with 5.5 ml 
SOCl2 in 100 ml absolute MeOH as mentioned above, but at the second time, the 
reaction was kept at room temperature overnight. After removal of MeOH, the residue 
was transferred to 100 ml of EtOAc, washed with 20 ml cold 5% NaHCO3, and then 
washed with 5% NaCl until pH 7.0. The organic layer was dried over anhydrous 
Na2SO4 and concentrated in vacuo to dryness. The yield and analytical data are given 
in Table 4.1. 
 
(10) Preparation of Phac-Gly-OCam and Phac-Asp(OMe)-OCam 
Phac-Gly-OH (5.0 g, 26 mmol) [Phac-Asp(OMe)-OH (4.24 g, 16mmol)] was 
dissolved in 50 ml of MeOH/water (4:1) [296 ml of MeOH/water (2:1)] and 20 ml 
[13.64 ml] of 20% Cs2CO3  was added dropwise in 1 h. The solution was evaporated 
to dryness under vacuum (bath temperature＜45oC) and the residue was evaporated 3 
times with 50 ml toluene each. The white crystals (Phac-Gly-OCs) 
[Phac-Asp(OMe)-OCs] were dried overnight under high vacuum. The cesium salt was 
dissolved in 60ml [240 ml] absolute DMF. In this solution α-chloroacetamide (3.5 g, 
37.5mmol) [2.24 g, 24 mmol] was added. After the mixture was stirred for 4 d at 35oC, 
the solution was evaporated to dryness under vacuum. The residue was dissolved in 
100ml EtOAc, washed with water (3x100 ml), 5% (w/v) NaHCO3 (3x25 ml) and 
saturated NaCl solution (3x100 ml), dried over anhydrous Na2SO4 and finally 
evaporated to dryness under vacuum. A white solid was obtained. The yield and 
analytical data are given in Table 4.1.  
PhAc-Asp(OMe)-OCam: FABMS m/z 323.0 [M+H+], m/z 345.1 [M+Na+], 
C15H18N2O6 requires 322.2.  
 
(11) Preparation of Fmoc-Gly-OPfp, Fmoc-Trp-OPfp and Fmoc-Met-OPfp 
To a stirred, ice-cold solution of the Fmoc-amino acid (20 mmol) and 
pentafluorophenol (20 mmol) in 80 ml EtOAc with 20 ml DMF or 100 ml EtOAc, 
dicyclohexylcarbodiimide (20 mmol) was added and stirring was continued for 1 h at 
0oC and for 1 h at room temperature. Dicyclohexylurea was filtered off and the 
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solvent was evaporated in vacuo at 40oC. The residue was recrystallized in 
EtOAc/petroleum ether (for Fmoc-Trp-OPfp, Fmoc-Met-OPfp) or EtOAc (for 
Fmoc-Gly-OPfp). The yield and analytical data are given in Table 4.1. 
 
Table 4.1 Isolated yield, melting point, HPLC retention time and Rf value of obtained 
amino acid derivative 
 
Derivative Isolated 
Yield [%] 
m.p. [oC] HPLC System 
(3-6)/tR [min] 
TLC System 
(1-3)/Rf 
Phac-Gly 53.3 139-141 6/1.19 1/0.69 
Phac-Asp 51.8 129-133 6/0.94 1/0.68 
Phac-Gly-OMe 65.3 81-83 6/2.18 1/0.81 
Tyr-OMe·HCl 88.9 178-180 4/ 1.95 1/0.53 
Trp-OMe·HCl 78.3 210-212 6/3.33 1/0.55 
Phe-OMe·HCl 93.7 158-160 6/3.41 1/0.57 
Met-OEt·HCl 91.2 82-84 UV-inactive 1/0.63 
Asp(OEt)-OEt·HCl 80.0 104-106 UV-inactive 1/0.54 
Asp(OMe)-OMe·HCl 94.3 114-115 UV-inactive 1/0.43 
Asp(OBzl)-OBzl·TOS 90.2 154-157 UV-inactive 1/0.67 
Met-OBzl·TOS 33.6 129-131 UV-inactive 1/0.58 
Phe-NH2·HCl 85.0 230-235 6/1.19 1/0.54;  
Asp(OMe)-OH·HCl 66.0 193-195 UV-inactive 1/0.28 
Phac-Asp(OMe)-OH 49.7 100-102 4/1.13 1/0.65 
Z-Asp(OMe)-OH 65.1 95-96 6/1.96 3/0.2 
Phac-Asp(OMe)-OMe 93.2 71-73 4/7.29 1/0.74 
Phac-Gly-OCam 85.6 128-129 6/1.57 3/0.65 
Phac-Asp(OMe)-OCam 64.5 100-101 4/3.86 1/0.71 
Fmoc-Gly-OPfp 87.5 160-161 5/2.10 1/0.82 
Fmoc-Trp-OPfp 91.9 185-186 5/4.45 1/0.91 
Fmoc-Met-OPfp 99.5 101-103 5/4.99 1/0.85 
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4.8 Peptide synthesis 
4.8.1 Chemical synthesis of reference peptides 
4.8.1.1 Chemical synthesis of Phac-peptides 
 
(1) Chemical synthesis of Phac-dipeptide, -tripeptide and –tetrapeptide 
fragments 
20 mmol of HOBt were dissolved in 50 ml anhydrous THF and 20 mmol of 
Phac-Gly-OH or Phac-peptidyl acid in 60 ml DMF. 22 mmol of 3 M DCC in DCM 
were added. After stirring for 1 h, the DCU was removed by filteration. The filtrate 
was added into a solution of 20 mmol of amino acid ester hydrochloride in 60 ml 
DMF. The pH was adjusted to 8 by adding N-methylmorpholine. The mixture was 
stirred overnight, filtered and evaporated in vacuo to dryness. The residue was 
dissolved in 200 ml EtOAc and extracted with 1 M citric acid (3x50 ml), 10% 
Na2CO3 (3x50 ml) and saturated NaCl (3x50 ml). After drying over anhydrous NaSO4, 
filtration and concentration, the residue (Phac-peptidyl ester) was crystallized (Table 
4.2). 
 
To obtain Phac-peptidyl acid, 7 mmol of the corresponding Phac-peptidyl ester were 
dissolved in water/acetone (140 ml, 1:1 v/v) and treated with 4 ml 4 N NaOH. The 
reaction was controlled by TLC (TLC system 2). After the reaction was completed, 
acetone was removed in vacuo. The solution was acidified with 6 M HCl to pH 3.0, 
extracted with 110 ml EtOAc and washed with saturated NaCl to pH 7.0. After drying 
over anhydrous NaSO4, filtration and concentration, the product (Phac-peptidyl acid) 
was obtained (Table 4.2). 
Phac-Gly-Trp-Met-OH: FABMS m/z 511.1 [M+H+], m/z 533.2 [M+Na+], 
C26H30N4O5S1 requires 510.6.  
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Table 4.2 Analytical data of the synthesized Phac-peptide fragments. 
 
Phac-peptide Fragment Solvent for 
Recrystallizati-
on  
Isolated 
Yield 
[%] 
m.p. 
[oC] 
HPLC 
System 
(3-6)/tR[min] 
TLC 
System 
(1-3)/Rf 
Phac-Gly-Trp-OMe EtOAc/PE 67.3 126-128 6/10.27 1/0.79 
Phac-Gly-Trp-OEt EtOAc/PE 70.8 192-195 6/11.77 1/0.80 
Phac-Gly-Trp-OH ------------- 93.0 72-75 6/2.78 1/0.68 
Phac-Gly-Trp-Met-OEt EtOH 58.0 174-176 6/13.32 3/0.8 
Phac-Gly-Trp-Met-OH ------------- 98.6 180-182 6/5.15 3/0.15 
Phac-Gly-Trp-Met-Asp 
(OMe)-OMe 
EtOAc/PE 39.8 118-120 6/9.42 1/0.77 
Phac-Gly-Trp-Met-Asp 
(OH)-OH 
------------- 79.9 125-127 6/1.17 1/0.65 
 
(2) Chemical synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 and 
Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 
96 mg (0.15 mmol) of Phac-Gly-Trp-Met-Asp(OMe)-OH and 171 mg (0.75 mmol) of 
Phe-NH2·HCl were dissolved in as less as possible DMF. 26 µl 3 M DCC in DCM 
were added and the pH was adjusted to 8 by adding N-methylmorpholine. After 
stirring for 1 h, another 26 µl 3 M DCC in DCM were added. The mixture was stirred 
overnight, filtered and distillated in vacuo to dryness. The residue was dissolved in 
MeOH and prepared for size exclusion chromatography. The product fractions were 
pooled after checked by HPLC and concentrated. The crude product was dissolved in 
30 ml of 60% MeOH in water (v/v) and chromatographed with MPLC. The pure 
product (Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2) was lypholized twice after 
concentration of the pooled fractions and 52 mg (44.2%) of a white solid were 
obtained (decomposition at 220oC, HPLC system 6 with tR 13.95, FABMS m/z 786.1 
[M+H+], m/z 808.1 [M+Na+], C40H47N7O8S1 requires 785.9). 
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0.4 g (0.51 )mmol of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were dissolved in 100 
ml water/acetone (1:1 v/v) and treated with 1 ml 4 N NaOH. After 1 h the acetone was 
removed in vacuo. The product was precipitated by acidification with 1M HCl to pH 
3.0 and filtered. The residue was washed with 50 ml water. After drying over 
anhydrous NaSO4, filtration and concentration, the product 
Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 was obtained as a white solid (0.34 g, 86.8%, 
m.p. 214-2170C, HPLC system 6 with tR 10.88, FABMS m/z 772.9 [M+H+], m/z 
794.2 [M+Na+], C39H45N7O8S1 requires 771.9). 
 
4.8.1.2 Chemical synthesis of the C-terminal pentapeptides 
 
(1) Hydrogenation of Z-Asp(OMe)-Phe-NH2 
2 g (4.7 mmol) of Z-Asp(OMe)-Phe-NH2 were completely dissolved in 320 ml of 
MeOH and 0.8 ml of 6 M HCl, and then 100 mg of 10% Pd-C were added. After 
sucking the air out of the flask with water pump, gaseous H2 was led into it. The 
reaction was fininshed in 30 min. The reaction mixture was filtered and the filtrate 
was concentrated in vacuo to yield a white solid of Asp(OMe)-Phe-NH2·HCl (1.53g, 
99.0%, m.p. 155-158oC, HPLC system 6 with tR 1.85). 
 
(2) Chemical synthesis of Fmoc-Met-Asp(OMe)-Phe-NH2 
To a stirred solution of Asp(OMe)-Phe-NH2·HCl (1.98 g, 6 mmol) in DMF (30 ml), 
Fmoc-Met-OPfp (3.23 g, 6 mmol) and Et3N (1.68 ml, 12 mmol) were added and 
stirring was contiuned for 20 min, then the solution was concentrated in vacuo. The 
residue crystallized by trituration with ether, giving Fmoc-Met-Asp(OMe)-Phe-NH2 
(3.09 g, 80.5%, m.p. 169-171oC, HPLC system 5 with tR 6.28). An analytical sample 
was recrystallized from methanol (FABMS m/z 647.0 [M+H+], m/z 669.2 [M+Na+], 
C34H38N4O7S1 requires 646.8). 
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(3) Chemical synthesis of Fmoc-Trp-Met-Asp(OMe)-Phe-NH2 
The above protected tripeptide amide (2.912 g, 4.5 mmol) was treated with a 10% 
dimethylamine solution in DMF (27 ml) for 10 min, then the solution was 
concentrated in vacuo. The residue was triturated with petroleum ether, then filtered 
off to give Met-Asp(OMe)-Phe-NH2 (1.89 g, 99.1%, m.p. 148-150oC, HPLC system 5 
with tR 9.29, FABMS m/z 425.0 [M+H+], m/z 447.1 [M+Na+], C19H28N4O5S1 requires 
424.5). 
 
To a stirred solution of this compound (2.035 g, 4.8 mmol) in DMF (24 ml), 
Fmoc-Met-OPfp (2.846 g, 4.8 mmol) and Et3N (0.672 ml, 4.8 mmol) were added and 
stirring was contiuned for 20 min, then the solution was concentrated in vacuo. The 
residue crystallized by trituration with EtOAc, giving 
Fmoc-Trp-Met-Asp(OMe)-Phe-NH2 (3.75 g, 93.8%, m.p. 182-183oC, HPLC system 5 
with tR 8.92, FABMS m/z 833.0 [M+H+], m/z 855.0 [M+Na+], C45H48N6O8S1 requires 
832.9). 
 
(4) Chemical synthesis of Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
The above protected tetrapeptide amide (3.744 g, 4.5 mmol) was treated with a 10% 
dimethylamine solution in DMF (28.125 ml) for 10 min, then the solution was 
concentrated in vacuo. The residue was triturated with petroleum ether, then filtered 
off to give Trp-Met-Asp(OMe)-Phe-NH2 (2.74 g, 99.8%, decomposition at 169oC, 
HPLC system 5 with tR 9.08, FABMS m/z 611.0 [M+H+], m/z 633.0 [M+Na+], 
C30H38N6O6S1 requires 610.7). 
 
To a stirred solution of this compound (3.05 g, 5 mmol) in DMF (30 ml), 
Fmoc-Gly-OPfp (2.315 g, 5 mmol) and Et3N (0.7 ml, 5 mmol) were added and 
stirring was contiuned for 20 min, then the solution was concentrated in vacuo. The 
residue crystallized by trituration with EtOAc, giving 
Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (3.26 g, 73.7%, m.p. 166-170oC, HPLC  
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system 5 with tR 7.27, FABMS m/z 890.3 [M+H+], m/z 912.3 [M+Na+], 
C47H51N7O9S1 requires 889.9). 
 
(5) Removal of Fmoc from Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (535 mg, 0.6 mmol) was treated with a 10% 
dimethylamine solution in DMF (5 ml) for 10 min, then the solution was concentrated 
in vacuo. The residue was triturated with petroleun ether, then filtered off to give 
Gly-Trp-Met-Asp(OMe)-Phe-NH2 (200 mg, 50.0%, decomposition at 210oC, HPLC 
system 5 with tR 1.36, FABMS m/z 668.0 [M+H+], m/z 690.2 [M+Na+], 
C32H41N7O7S1 requires 667.8). 
 
(6) Removal of Fmoc and OMe from Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (178 mg, 0.2 mmol) was suspended in 
water/acetone (10 ml, 1:1 v/v) and treated with 0.5 ml 4 N NaOH for 1 h, then the 
solution was concentrated in vacuo to remove acetone. The residue was neutralized to 
pH 7.0, white solid (Gly-Trp-Met-Asp(OH)-Phe-NH2) came out, was filtered off and 
dried (33 mg, 25.3%, decomposition at 230oC, HPLC system 6 with tR 6.73, FABMS 
m/z 654.2 [M+H+], m/z 676.2 [M+Na+], C31H39N7O7S1 requires 653.7). 
4.8.2 Enzymatic synthesis of peptides 
(1) Synthesis of Z-Asp(OMe)-Phe-NH2 with thermolysin 
5.0 g (17.8 mmol) Cbo-Asp(OMe)-OH and 4.6 g (23.0 mmol) H-Phe-NH2·HCl were 
suspended in 80 ml H2O and the pH was adjusted to 7.0 with 1N NaOH. To this 
solution 25 mg thermolysin were added and stirred at 40°C. After 7h the reaction was 
complete and no starting material was detected by TLC. The precipitated white 
product Z-Asp(OMe)-Phe-NH2 was isolated by filtration, washed with cold 5% citric 
acid (3x100 ml) and cold water (3x100 ml) successively, and then dried in vacuum 
(6.88 g, 90.6%, m.p. 185-186oC, HPLC system 6 with tR 11.46, FABMS m/z 428.1 
[M+H+], m/z 450.1 [M+Na+], C22H25N3O6 requires 427.5. TLC system 3 with Rf = 
0.5). 
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(2) Synthesis of Phac-Asp(OMe)-Tyr-OMe with papain/VA-Epoxy in low-water 
content system 
16 mg (0.068 mmol) Tyr-OMe·HCl and 32 mg (0.1 mmol) Phac-Asp(OMe)-OCam 
were dissolved in 1.5 ml EtOAc, 3 µl 0.1 M borax buffer (pH 8.2), 2 µl 
β-mercaptoethanol and 0.2 mg EDTA. To this solution 200 mg papain/VA-Epoxy 
were added and thoroughly mixed by rotating at room temperature. The reaction was 
monitored by HPLC. After 2 h the HPLC yield was 25.5%. The mixture was filtered 
to remove the immobilized enzyme which was washed with a mixture of 40 ml ACN 
and 10 ml water. The combined filtrates were evaporated to dryness in vacuo and the 
residue was dissolved in 40% MeOH and separated by preparative HPLC with 55% 
eluent B. The pooled fractions were lyophilized twice yielding a white powder 
Phac-Asp(OMe)-Tyr-OMe (7 mg, 23.3%, m.p. 130-133ºC, HPLC system 4 with tR 
10.96, FABMS m/z 443.1 [M+H+], m/z 465.1 [M+Na+], C23H26N2O7 requires 442.5). 
 
A by-product was isolated (6 mg, 14.6%) and characterized as Phac- 
Asp(OMe)-Tyr-Tyr-OMe by FABMS m/z 606.1 [M+H+], m/z 628.1 [M+Na+], 
C32H35N3O9 requires 605.6, HPLC system 4 with tR 13.78, decomposition at 220ºC. 
 
(3) Synthesis of Phac-Asp(OMe)-Tyr-OAl with papain/VA-Epoxy 
0.5 mmol Tyr-OAl or Tyr-OAl·TOS and 256 mg (0.8 mmol) Phac-Asp(OMe)-OR (R 
= Me, Cam) were dissolved in 12 ml organic solvent, 24 µl 0.1 M borax buffer, 16 µl 
β-mercaptoethanol and 1.6 mg EDTA. To this solution papain/VA-Epoxy was added 
and thoroughly mixed by rotating at room temperature. The reaction was monitored 
by HPLC. After reaching the “kinetic” optimum, the mixture was filtered to remove 
the immobilized enzyme which was washed with a mixture of 40 ml ACN and 10 ml 
water. The combined filtrates were evaporated to dryness in vacuo and the residue 
was dissolved in 40% MeOH and separated by MPLC. The pooled fractions were 
lyophilized twice yielding a white powder Phac-Asp(OMe)-Tyr-OAl (m.p. 91-93ºC, 
HPLC system 4 with tR 12.88, FABMS m/z 469.1 [M+H+], m/z 491.0 [M+Na+], 
C25H28N2O7 requires 468.3). The experimental data are shown in Table 4.3. 
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Table 4.3 Experimental data for synthesis of Phac-Asp(OMe)-Tyr-OAl with 
papain/VA-Epoxy. 
 
R Amino 
Component 
Catalyst 
[g] 
Reaction 
Media 
pH Value 
of Borax 
Buffer 
HPLC 
Yield 
[%] 
Isolated 
Yield 
[%] 
Me Tyr-OAl·TOS 1.6 EtOAc + 7  
mg NaOH 
8.2 0 0 
Cam Tyr-OAl·TOS 1.6 ACN + 7  
mg NaOH 
8.2 14.9 ------ 
Cam Tyr-OAl·TOS 1.6 EtOAc + 7  
mg NaOH 
8.2 27.9 22.2 
Cam Tyr-OAl 1.6 EtOAc  8.2 25.2 22.6 
Cam Tyr-OAl 1 EtOAc +  
100µl ACN 
8.2 30.1 24.0 
Cam Tyr-OAl 1 EtOAc +  
100µl ACN 
5.9 24.3 17.8 
Cam Tyr-OAl 1 EtOAc  6.9 40.7 33.8 
Cam Tyr-OAl 1 EtOAc +  
100µl ACN 
6.9 57.3 40.1 
Cam Tyr-OAl 1 EtOAc +  
1ml ACN 
6.9 30.5 26.1 
 
The HPLC yields of the by-product were shown in Table 3.1. The by-product was 
isolated and characterized as Phac-Asp(OMe)-Tyr-Tyr-OAl by FABMS m/z 632.2 
[M+H+], m/z 654.2 [M+Na+], C34H37N3O9 requires 631.3, HPLC system 4 with tR 
13.78, m.p. 108-110ºC. 
 
(4) Synthesis of Phac-Asp(OR)-Tyr-OAl with free or immobilized thermolysin 
265 mg (1 mmol) Phac-Asp(OR)-OH (R = H, Me) and 2 mmol Tyr-OAl·TOS or 
Tyr-OAl were dissolved in the reaction media and the pH was adjusted to 7.0 with 1M 
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NaOH. To this solution free or immobilized thermolysin was added and thoroughly 
mixed by rotating. After 5 d, the mixture was washed with ACN and filtered. The 
filtrate was evaporated to dryness under vacuum. The residue was dissolved in 30% 
MeOH and separated by MPLC. The pooled fractions of Phac-Asp(OR)-Tyr-OAl 
were lyophilized twice yielding a white powder. The experimental data are shown in 
Table 4.4. 
 
Table 4.4 Experimental data for synthesis of Phac-Asp(OR)-Tyr-OAl via the catalysis 
of free or immobilized thermolysin . 
 
R Amino 
Component 
Catalyst 
 
Reaction Media Temperature 
[oC] 
Isolated Yield 
[%] 
H Tyr-OAl·TOS 400 mg 
TLN/Celite- 
545 
3.6 ml ACN + 
200 µl 0.05 M 
HCl-Tris 
25 0 
H Tyr-OAl·TOS 10 mg TLN 4 ml 0.05 M 
HCl-Tris 
25 0 
Me Tyr-OAl·TOS 400 mg  
TLN/Celite- 
545 
3.6 ml ACN +  
200 µl 0.05 M  
HCl-Tris 
25 0 
Me Tyr-OAl·TOS 100 mg  
TLN 
1.5 ml H2O 40 20.3 
Me Tyr-OAl 100 mg  
TLN 
1.5 ml H2O + 
40 µl ACN 
40 15.4 
 
(5) Synthesis of Phac-Asp(OMe)-Tyr-OH with papain and 
Phac-Asp(OMe)-Tyr-OMe with papain/VA-Epoxy in the solvent-free system 
556 mg (2.4 mmol) Tyr-OMe·HCl, 3.2 g (32 mmol) KHCO3 and 686 mg (2.4 mmol) 
Na2CO3·10H2O were mixed. 446 mg (1.6 mmol) Phac-Asp(OMe)-OMe and 240 mg 
papain or 1.2 g papain/VA-Epoxy were added and stirred manually from time to time. 
After 1 d, the mixture was washed with ACN and filtered. The filtrate was evaporated 
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to dryness under vacuum. The residue was dissolved in 30% MeOH and separated by 
MPLC. The pooled fractions were lyophilized twice yielding a white powder. 
Phac-Asp(OMe)-Tyr-OH: reaction via the catalysis of free papain, 328 mg, 76.6% 
(isolated yield), m.p. 158-159ºC, HPLC system 4 with tR 3.38, FABMS m/z 429.1 
[M+H+], m/z 451.1 [M+Na+], C22H24N2O7 requires 428.2.  
 
Phac-Asp(OMe)-Tyr-OMe: reaction via the catalysis of papain/VA-Epoxy, 260 mg, 
36.8% (isolated yield), m.p. 130-133ºC. 
 
(6) Synthesis of Phac-Asp(OMe)-Tyr-Met-OR with papain/VA-Epoxy  
Met-OR (1.0 mmol Met-OEt, 1.0 mmol Met-OBzl or 0.75 mmol Met-OAl) and 113 
mg (0.25 mmol) Phac-Asp(OMe)-Tyr-OAl were dissolved in 7.5 ml EtOAc, 15 µl 
buffer, 10 µl β-mercaptoethanol and 1 mg EDTA. To this solution 1 g 
papain/VA-Epoxy was added and thoroughly mixed by rotating at room temperature. 
After reaching the “kinetic” optimum within 3-4 h, the mixture was filtered to remove 
the immobilized enzyme which was washed with a mixture of 40 ml ACN and 10 ml 
water. The combined filtrates were evaporated to dryness in vacuo and the residue 
was dissolved in 40% MeOH and separated by MPLC. The pooled fractions were 
lyophilized twice yielding a white powder. 
 
Product Phac-Asp(OMe)-Tyr-Met-OEt: Reaction in 0.1 M borax buffer (pH 6.9), 
HPLC yield 55.2%, isolated yield 55 mg, (37.5%), m.p.141-143ºC, HPLC system 4 
with tR 11.49, FABMS m/z 588.2 [M+H+], m/z 610.2 [M+Na+], C29H37N3O8S1 
requires 587.2. A by-product was isolated (5 mg, 13.9%) and characterized as 
Phac-Asp(OMe)-Tyr-Met-Met-OEt by FABMS m/z 719.2 [M+H+], m/z 741.2 
[M+Na+], C34H46N4O9S2 requires 718.2, HPLC system 4 with tR 12.56, decomposition 
at 180ºC. 
 
Product Phac-Asp(OMe)-Tyr-Met-OBzl: Reaction in 0.1 M borax buffer (pH 6.9), 
HPLC yield 29.5%, isolated yield 15 mg, (9.2%), m.p. 90-92ºC, HPLC system 4 with 
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tR 15.31, FABMS m/z 650.4 [M+H+], m/z 672.4 [M+Na+], C34H39N3O8S1 requires 
649.2. When the reaction was carried out for 21 h, the main product was 
Phac-Asp(OMe)-Tyr-Met-OH: Isolated yield 31 mg (22.4%), decomposition at 230ºC, 
HPLC system 4 with tR 7.32, FABMS m/z 560.2 [M+H+], m/z 582.1 [M+Na+], 
C27H33N3O8S1 requires 559.2. 
 
Product Phac-Asp(OMe)-Tyr-Met-OAl: reaction in 0.1 M borax buffer (pH 6.9), 
HPLC yield 64.4%, isolated yield 63 mg, (42.1%); reaction in 0.1 M borax buffer (pH 
5.9), HPLC yield 67.5%; reaction in 0.1 M borax buffer (pH 8.0), HPLC yield 62.9%; 
m.p. 161-163ºC, HPLC system 4 with tR 14.36, FABMS m/z 600.3 [M+H+], m/z 622.2 
[M+Na+], C30H37N3O8S1 requires 599.2. A by-product (HPLC yield around 10%) was 
isolated and characterized as Phac-Asp(OMe)-Tyr-Met-Met-OAl by FABMS m/z 
731.2 [M+H+], m/z 753.2 [M+Na+], C35H46N4O9S2 requires 730.2, HPLC system 4 
with tR 16.37, decomposition at 188ºC;. 
  
(7) Synthesis of Phac-Asp(OMe)-Tyr-Met-OEt with α-CHY/Celite-545 
23 mg (0.05 mmol) Phac-Asp(OMe)-Tyr-OAl, 42.8 mg (0.2 mmol) Met-OEt·HCl, 10 
mg (0.1 mmol) KHCO3 and 24 mg (0.08 mmol) Na2CO3·10H2O were mixed. 150 mg 
of α-CHY/Celite-545 were added and stirred manually every 20 min. The reaction 
was monitored by HPLC. The HPLC yield of Phac-Asp(OMe)-Tyr-Met-OEt was 
11.0%. 
 
(8) Synthesis of Phac-Asp(OMe)-Tyr-Met-OAl with α-CHY/Celite-545 
113 mg (0.25 mmol) Phac-Asp(OMe)-Tyr-OAl, 361 mg (1 mmol) Met-OAl·TOS, 50 
mg (0.5 mmol) KHCO3 and 120 mg (0.4 mmol) Na2CO3·10H2O were mixed. 750 mg 
of α-CHY/Celite-545 were added and stirred manually every 20 min. The reaction 
was monitored by HPLC. After 5 h, the HPLC yield was 46.3%. The mixture was 
washed with EtOAc and filtered. The filtrate was evaporated to dryness under vacuum. 
The residue was dissolved in 40% MeOH and separated by MPLC. The pooled 
fractions were lyophilized twice yielding a white powder of Phac-Asp(OMe)-Tyr- 
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Met-OAl (63 mg, 42.1%, m.p. 161-163ºC). To increase the yield, unreacted substates 
were recycled for a repeated conversion and an overall yield of 65.2% could be 
obtained. 
 
(9) Synthesis of Phac-Asp(OMe)-Tyr-Met-OAl with thermolysin 
220 mg (0.5 mmol) Phac-Asp(OMe)-Tyr-OH and 189 mg (1 mmol) Met-OAl were 
dissloved in 750 µl H2O with 20 µl ACN and the pH was adjusted to 7.0 with 1N 
NaOH. After addition of 30 mg thermolysin, the mixture was stirred at 40°C. After 30 
min, the reaction was complete and the HPLC yield was 81.9%. The mixture was 
filtered and washed with ACN. The filtrate was evaporated to dryness under vacuum. 
The residue was dissolved in 30% MeOH and separated by MPLC. The pooled 
fractions were lyophilized twice yielding a white powder Phac-Asp(OMe)-Tyr-Met- 
OAl (174 mg, 58.2 %, m.p. 161-163ºC). 
 
(10) Synthesis of Phac-Gly-Trp-OMe with papain/VA-Epoxy 
125 mg (0.5 mmol) Phac-Gly-OCam and 164 mg (0.75 mmol) H-Trp-OMe were 
dissolved in 50 ml EtOAc containing 270 µl 0.2 M borax buffer (pH 8.5), 30 µl 
β-mercaptoethanol, and 1 mg EDTA. To this solution 300 mg papain/VA-Epoxy were 
added and thoroughly mixed by rotating. After 3 h the reaction was complete and the 
HPLC yield was 97%. The mixture was filtered to remove the immobilized enzyme 
which was washed with a mixture of 40 ml ethyl acetate and 10 ml water. The 
combined filtrates were extracted successively with 1M citric acid (3x100 ml), 5% 
NaHCO3 (3x100 ml), and saturated sodium chloride (1x100 ml). The organic phase 
was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue 
was lyophilized yielding a white solid of Phac-Gly-Trp-OMe (174 mg, 88.4%, m.p. 
126-128ºC, HPLC system 6 with tR 10.27, FABMS m/z 394.1 [M+H+], C22H23N3O4 
requires 393.5).  
 
(11) Synthesis of Phac-Gly-Trp-Met-OEt with immobilized α-chymotrypsin 
5.0 mmol Phac-Gly-Trp ester, 4.28 g (20.0 mmol) Met-OEt·HCl, 10 g (100 mmol) 
KHCO3 and 5.72 g (20.0 mmol) Na2CO3·10H2O were mixed. Immobilized 
α-chymotrypsin was added and stirred manually every 20 min. The reaction was 
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monitored by HPLC (system 6). After the reaction was finished, the mixture was 
washed with water until a pH of 7.0 was reached, diluted with 100 ml 80% EtOH and 
then sonicated to extract the tripeptide. After removal of the immobilized enzyme by 
filtration, the solvent was evaporated to dryness under vacuum. The tripeptide ester 
Phac-Gly-Trp-Met-OEt was obtained by recrystallization with EtOH as a white solid 
(m.p. 174-176ºC, HPLC system 6 with tR 13.32, FABMS m/z 539.1 [M+H+], m/z 
561.2 [M+Na+], C28H34N4O5S1 requires 538.6). The experimental data are shown in 
Table 4.5. 
 
Table 4.5 Experimental data for synthesis of Phac-Gly-Trp-Met-OEt with 
immobilized α-chymotrypsin. 
 
Carboxyl Component Amino 
Component 
Catalyst Isolated Yield 
 [%] 
Phac-Gly-Trp-OMe Met-OEt·HCl 2.0 g α-CHY/Celite-545 71.4 
Phac-Gly-Trp-OMe Met-OEt·HCl 2.5 g α-CHY/Eupergit C 65.2 
Phac-Gly-Trp-OEt Met-OEt·HCl 2.5 g α-CHY/Eupergit C 65.3 
 
(12) Synthesis of Phac-Gly-Trp-Met-OAl with immobilized α-chymotrypsin  
474 mg (1.2 mmol) Phac-Gly-Trp-OMe, 600 mg (1.66 mmol) Met-OAl·TOS, 120 mg 
(1.2 mmol) KHCO3 and 105 mg (0.367 mmol) Na2CO3·10H2O were mixed. 
Immobilized α-chymotrypsin was added and stirred manually every 20 min. The 
reaction was monitored by HPLC (system 6). After the reaction was finished, to the 
mixture 20 ml water was added, transferred to a sintered glass frit and washed with 
water until the filtrate showed a pH of 7.0. The filter cake was diluted with 100 ml 
80% EtOH and then sonicated to extract the tripeptide. After removal of the 
immobilized enzyme by filtration, the solvent was evaporated to dryness under 
vacuum. The tripeptide ester Phac-Gly-Trp-Met-OAl was obtained by 
recrystallization with EtOH as a white solid (m.p. 176-178ºC, HPLC system 6 with tR 
14.51, FABMS m/z 551.1 [M+H+], C29H34N4O5S1 requires 550.6). The experimental 
data are shown in Table 4.6. 
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Table 4.6 Experimental data for synthesis of Phac-Gly-Trp-Met-OAl via immobilized 
α-chymotrypsin. 
 
Carboxyl Component 
Amino 
Component 
Catalyst 
Isolated Yield 
 [%] 
Phac-Gly-Trp-OMe Met-OAl·TOS 1.5 g α-CHY/Celite-545 58.5 
Phac-Gly-Trp-OMe Met-OAl·TOS 1.5 g α-CHY/Eupergit C 42.0 
 
(13) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OMe with papain/VA-Epoxy 
0.31 g (0.6 mmol) Phac-Gly-Trp-Met-OH, and 0.16 g (1 mmol) Asp(OMe)-OMe were 
dissolved in 10 ml organic solvent, 0.2 ml 0.2 M borax buffer (pH 8.1), 0.02 ml 
β-mercaptoethanol and 0.2 mg EDTA. To this solution 1.0 g papain/VA-Epoxy were 
added and thoroughly mixed by rotating. The reaction was monitored by HPLC 
(system 6).  After reaction, the mixture was filtered to remove the immobilized 
enzyme which was washed with a mixture of 40 ml ethyl acetate and 10 ml water. The 
combined filtrates were extracted successively with 1M citric acid (2x10 ml), 5% 
NaHCO3 (2x10 ml), and saturated sodium chloride (3x10 ml). The organic phase was 
dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was 
lyophilized yielding a white solid Phac-Gly-Trp-Met-Asp(OMe)-OMe (79.6%, mp. 
118-120ºC, HPLC system 6 with tR 9.42, FABMS m/z 654.0 [M+H+], m/z 676.8 
[M+Na+], C32H39N5O8 S1 requires 653.8). The experimental data are shown in Table 
4.7. 
 
Table 4.7 Experimental data for the synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OMe 
with papain/VA-Epoxy from Phac-Gly-Trp-Met-OH and Asp(OMe)-OMe. 
 
Organic Solvent 
Reaction Time 
[h] 
HPLC Yield 
 [%] 
Isolated Yield 
 [%] 
EtOAc 75 89.0 79.6 
ACN 84 36.6 21.7 
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(14) Investigation of synthesizing Phac-Gly-Trp-Met-Asp(OMe)-OMe from 
Phac-Gly-Trp-Met-OEt  
54 mg (0.1 mmol) Phac-Gly-Trp-Met-OEt, and 100 mg (0.5 mmol) 
Asp(OMe)-OMe·HCl were stirred in different reaction system under the catalysis of 
papain or α-chymotrypsin. When papain was used, the reaction media contained 6 µl 
β-mercaptoethanol and 0.5 mg EDTA. The reaction was monitored by HPLC (system 
6).  The experimental data are shown in Table 4.8. 
 
Table 4.8 Experimental data for investigation of synthesizing Phac-Gly-Trp-Met- 
Asp(OMe)-OMe from Phac-Gly-Trp-Met-OEt and Asp(OMe)-OMe·HCl . 
 
Reaction 
System 
Reaction Media Catalyst 
Reaction 
pH 
Reaction 
Time [d] 
HPLC 
Yield 
[%] 
4 mg Papain ----- 1 0 Solvent-free 
system 
0.2 mmol  
KHCO3 + 0.4  
mmol 
Na2CO3·10H2O 
2 mg  
α-Chymotrypsin 
----- 1 0 
Buffer system 2 ml 0.2 M  
KH2PO4 
4 mg Papain 5.9 3 0 
Cosolvent 
system 
0.45 ml ACN 
+1.05 ml 0.2 M 
KH2PO4 
4 mg Papain 5.9 3 0 
 
(15) Investigation of synthesizing Phac-Gly-Trp-Met-Asp(OMe)-OMe from 
Phac-Gly-Trp-Met-OAl or Phac-Gly-Trp-Met-OCam  
0.6 mmol Phac-Gly-Trp-Met-OR (R=Al or Cam), and 160 mg (1 mmol) 
Asp(OMe)-OMe were dissolved in 10 ml EtOAc, 0.2 ml 0.2 M borax buffer (pH 8.1), 
0.02 ml β-mercaptoethanol and 0.2 mg EDTA. To this solution 1.0 g 
papain/VA-Epoxy were added and thoroughly mixed by rotating. The reaction was 
monitored by HPLC (system 6). After 22 h, no coupling reaction was observed.  
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(16) Selective hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe with 
α-CHY/Eupergit C 
264 mg (0.4 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OMe were dissolved in 4.8 ml 
ACN with 10.8 ml 0.05 M Tris-HCl buffer and 80 µl triethylamine. After adjusting 
the pH to 7.0, 800 mg α-CHY/Eupergit C was added and thoroughly mixed by 
rotating. The reaction was completed after 32 h. To extract the product, the mixture 
was diluted with 3x50 ml 80% MeOH, sonicated, and filtered. The filtrate was 
evaporated to dryness under vacuum. 30 ml water was added to the residue, which 
was extracted with 3x30 ml EtOAc. The aqueous layer was acidified to pH 3.0 with 6 
M HCl and extracted with 3x30 ml EtOAc. The organic layer was dried over 
anhydrous Na2SO4 and concentrated. The residue was recrystallized with EtOH to 
yield the product Phac-Gly-Trp-Met-Asp(OMe)-OH (163 mg, 63.7%, m.p. 150-152oC, 
HPLC system 6 with tR 6.02, FABMS m/z 640.0 [M+H+], m/z 662.1 [M +Na+], 
C31H37N5O8S1 requires 639.7). 
  
In another experiment, 1.6 ml acetonitrile with 3.6 ml 0.05 M Tris-HCl buffer was 
used instead of 4.8 ml acetonitrile with 10.8 ml 0.05 M Tris-HCl buffer. The isolated 
yield of Phac-Gly-Trp-Met-Asp(OMe)-OH was 52.2%. 
 
(17) Selective hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe with papain 
261 mg (0.4 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OMe were suspended in 11 ml 0.2 
M KH2PO4 buffer (pH 7.5), 16 µl β-mercaptoethanol and 1.6 mg EDTA. After 
adjusting the pH to 6 with 1 M HCl, 15 mg papain was added and mixed by stirring. 
The reaction was monitored by HPLC (system 6). The HPLC yield was 36.2% after 4 
h. 
 
(18) Selective hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe with 
α-chymotrypsin 
33 mg (0.05 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OMe were dissolved in 0.2 ml 
acetonitrile, 0.45 ml 0.05 M Tris-HCl buffer and 3 µl triethylamine. 10 mg 
α-chymotrypsin was added and thoroughly mixed by rotating. The reaction was 
monitored by HPLC (system 6). The experimental data are shown in Table 4.9 and 
Figure 3.16. 
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Table 4.9 Experimental data for selective hydrolysis of Phac-Gly-Trp-Met- 
Asp(OMe)-OMe with α-chymotrypsin. 
 
Reaction pH Reaction Time [h] HPLC Yield [%] 
5.6 19 24.4 
7.0 19 52.0 
8.0 24 35.5 
 
(19) Selective hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-OMe with different 
types of α-chymotrypsin 
33 mg (0.05 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OMe were dissolved in 0.6 ml 
acetonitrile, 1.35 ml 0.05 M Tris-HCl buffer and 10 µl triethylamine. After adjusting 
the pH to 7.0, α-chymotrypsin or immobilized α-chymotrypsin was added and 
thoroughly mixed by rotating. The reaction was monitored by HPLC (system 6). The 
experimental data are shown in Table 3.5. 
 
(20) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH with α-chymotrypsin 
100 mg (0.2 mmol) Phac-Gly-Trp-Met-OH and 240 mg (1.2 mmol) 
Asp(OMe)-OMe·HCl were suspended in 3 ml of 0.2 M Na2HPO4 buffer (pH 9.3). 
After adjusting the reaction mixture to pH 7.3, 20 mg α-chymotrypsin was added and 
the reaction mixture was stirred at room temperature. The reaction was monitored by 
HPLC (system 6). No coupling reaction was obseverd but Phac-Gly-Trp-OH was 
obtained in HPLC yield of 30.7% after 8 h. 
 
(21) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH with papain 
300 mg (0.6 mmol) Phac-Gly-Trp-Met-OH and 600 mg (3 mmol) 
Asp(OMe)-OMe·HCl were suspended in 10 ml of 0.2 M KH2PO4 buffer, 36 µl 
β-mercaptoethanol and 3 mg EDTA. After adjusting the reaction mixture to different 
pH values, 30 mg papain were added and the reaction mixture was stirred at room 
temperature. The reaction was monitored by HPLC (system 6). The experimental data 
are shown in Table 4.10 and Figure 3.17. 
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Table 4.10 Experimental data for synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH with 
papain from Phac-Gly-Trp-Met-OH and Asp(OMe)-OMe·HCl. 
 
Reaction pH Reaction Time [h] HPLC Yield [%] 
5.0 1 17.9 
5.5 4 33.7 
6.0 24 33.3 
6.5 24 28.4 
7.0 24 21.2 
7.5 24 12.4 
 
(22) Synthesis of Phac-Gly-Trp-Met-Ap(OMe)-OH with papain in solvent-free 
system 
100 mg (0.2 mmol) Phac-Gly-Trp-Met-OH, 200 mg (1 mmol) Asp(OMe)-OMe·HCl, 
40 mg (0.4 mmol) KHCO3, 229 mg (0.8 mmol) Na2CO3·10H2O, 12 µl 
β-mercaptoethanol and 1 mg EDTA were mixed. 8 mg papain were added and stirred 
manually from time to time. The reaction was monitored by HPLC (system 6). After 3 
days, no coupling reaction was observed. 
 
(23) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH with papain/VA-Epoxy in 
different reaction systems 
100 mg (0.2 mmol) Phac-Gly-Trp-Met-OH and 200 mg (1 mmol) 
Asp(OMe)-OMe·HCl were suspended in different reaction media with 12 µl 
β-mercaptoethanol and 1 mg EDTA. After adjusting the reaction mixture to pH 5.9, 
200 mg papain/VA-Epoxy were added and the mixture was rotated at room 
temperature. The reaction was monitored by HPLC (system 6). The experimental data 
are shown in Table 3.2. 
 
(24) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH with papain/VA-Epoxy at 
different temperatures 
100 mg (0.2 mmol) Phac-Gly-Trp-Met-OH and 200 mg (1 mmol) 
Asp(OMe)-OMe·HCl were suspended in 1.5 ml of 0.2 M KH2PO4 buffer (pH 8.5), 12 
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µl β-mercaptoethanol and 1 mg EDTA. After adjusting the reaction mixture to pH 5.9, 
200 mg papain/VA-Epoxy was added into it and the mixture was rotated at different 
temperatures. The reaction was monitored by HPLC (system 6). The experimental 
data are shown in Table 3.3. 
 
(25) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-OH with papain/VA-Epoxy 
500 mg (1.0 mmol) Phac-Gly-Trp-Met-OH and 1 g (5.1 mmol) Asp(OMe)-OMe·HCl 
were suspended in 7.5 ml of 0.2 M KH2PO4 buffer (pH 8.5), 60 µl β-mercaptoethanol 
and 5 mg EDTA. After adjusting the reaction mixture to pH 5.9, 1 g papain/VA-Epoxy 
was added and the reaction mixture was rotated at 37oC. The reaction was monitored 
by HPLC (system 6) and stopped when the reaction reached its optimum. The mixture 
was filtered and washed with 3x50 ml 80% MeOH. The filtrate was concentrated to 
dryness. The residue was dissolved in 40% MeOH and separated by MPLC. The 
pooled fractions of Phac-Gly-Trp-Met-Asp(OMe)-OH were lyophilized twice yielding 
a white powder (239 mg, 37.4 %, m.p. 150-152ºC). The pooled fractions of the staring 
material Phac-Gly-Trp-Met-OH were lyophilized twice and were used for a repeated 
conversion, which allowed to increase the yield from 37.4% to 53.0%. 
 
(26) Synthesis of Phac-Gly-Trp-Met-Asp(OR)-OH with papain 
200 mg (0.4 mmol) Phac-Gly-Trp-Met-OH and 2 mmol Asp(OR)-OR·HCl (R = Me, 
Et) were suspended in 6 ml of 0.2 M KH2PO4 buffer, 24 µl β-mercaptoethanol and 2 
mg EDTA. After adjusting the reaction mixture to pH 5.9, 16 mg papain was added 
and the reaction mixture was stirred at 37oC. The reaction was monitored by HPLC 
(system 6) and stopped the reaction at its optimal point. The mixture was filtered and 
washed with 3x50 ml 80% MeOH. The filtrate was concentrated to dryness. The 
residue was dissolved in 40% MeOH and separated by MPLC. The pooled fractions 
of Phac-Gly-Trp-Met-Asp(OR)-OH were lyophilized twice yielding a white powder. 
The experimental data are shown in Table 4.11. 
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Table 4.11 Experimental data for synthesis of Phac-Gly-Trp-Met-Asp(OR)-OH via 
papain from Phac-Gly-Trp-Met-OH. 
 
R Product Reaction 
Time [h] 
HPLC 
Yield [%] 
Isolated 
Yield [%] 
Me Phac-Gly-Trp-Met-Asp(OMe)-OH 2.5 46.1 24.0 
Et Phac-Gly-Trp-Met-Asp(OEt)-OH 1 21.1 5.9 
 
Phac-Gly-Trp-Met-Asp(OEt)-OH: decomposition at 155ºC, HPLC system 6 with tR 
10.05, FABMS m/z 654.2 [M+H+], m/z 676.1 [M+Na+], C32H39N5O8S1 requires 653.2.  
 
(27) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 with thermolysin in 
water 
128 mg (0.2 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OH and 200 mg (1.0 mmol) 
Phe-NH2·HCl were suspended in 1.1 ml water. After adjusting the reaction mixture to 
pH 7.0 with 1 M NaOH, 0.3 mg thermolysin were added and the reaction mixture was 
stirred at room temperature. After 6.5 h, the mixture was filtered and washed with 
3x50 ml MeOH. The filtrate was concentrated to dryness. The residue was dissolved 
in 50% MeOH and separated by MPLC. The pooled fractions of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were lyophilized twice yielding a white 
powder (71 mg, 45.2%, decomposition at 220oC, HPLC system 6 with tR 13.95, 
FABMS m/z 786.1 [M+H+], m/z 808.1 [M+Na+], C40H47N7O8S1 requires 785.9). 
 
A by-product was isolated (10 mg, 9.5%) and characterized as Phac-Gly-Trp-Phe- 
NH2 by FABMS m/z 526.2 [M+H+], m/z 548.1 [M+Na+], C30H31N5O4 requires 525.6, 
HPLC system 6 with tR 11.99, m.p. 188-190ºC. 
 
(28) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 with thermolysin in the 
solvent-free system 
100 mg (0.16 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OH, 156 mg (0.78 mmol) 
Phe-NH2·HCl, 390 mg (3.9 mmol) KHCO3, 223 mg (0.78mmol) Na2CO3·10H2O, 
were mixed. 4 mg thermolysin were added and stirred manually from time to time. 
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The reaction was monitored by HPLC (system 6). After 22.5h, the HPLC yield of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was 1.7%. 
 
(29) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 with thermolysin in 
ACN at different temperatures 
100 mg (0.16 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OH and 156 mg (0.78 mmol) 
Phe-NH2·HCl were suspended in 4.2 ml acetonitrile containing 168 µl 0.05 M 
Tris-HCl buffer (pH 8.5). After adjusting the reaction mixture to pH 7.0 with 4 M 
NaOH, 4 mg thermolysin were added and the reaction mixture was stirred at different 
temperatures. For the reaction at 40oC, it was completed after 11 h. The mixture was 
filtered and washed with 3x50 ml 80% MeOH. The filtrate was concentrated to 
dryness. The residue was dissolved in 50% MeOH and separated by MPLC. The 
pooled fractions of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were lyophilized twice 
yielding a white powder (81 mg, 64.4%, decomposition at 220oC). The experimental 
data with yields are shown in Table 3.4. 
 
(30) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 with immobilized 
thermolysin in ACN 
100 mg (0.16 mmol) Phac-Gly-Trp-Met-Asp(OMe)-OH and 156 mg (0.78 mmol) 
Phe-NH2·HCl were suspended in 4.2 ml acetonitrile containing 168 µl 0.05 M 
Tris-HCl buffer (pH 8.5). After adjusting the reaction mixture to pH 7.0 with 4 M 
NaOH, immobilized thermolysin was added and the reaction mixture was stirred at 
40oC. The reaction was monitored by HPLC (system 6). The experimental data with 
yields are shown in Table 3.6. 
 
(31) Synthesis of Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 with thermolysin in 
water 
62 mg (0.1 mmol) Phac-Gly-Trp-Met-Asp(OH)-OH and 160 mg (0.8 mmol) 
Phe-NH2·HCl were suspended in 0.36 ml water. After adjusting the reaction mixture 
to pH 7.0 with 4 M NaOH, 0.06 mg thermolysin were added into it and the reaction 
mixture was stirred at room temperature. The reaction was monitored by HPLC 
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(system 6). After 1 day, the HPLC yield of Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 was 
5.5%. 
 
(32) Investigation of cleaving Phac-group from Phac-Gly-Trp-Met-Asp(OMe)- 
Phe-NH2 with PA/Eupergit C 
39 mg (0.05 mmol) Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were dissolved in 3 ml 
EtOH, 3 ml ACN and 8 ml 0.1 M Na2HPO4 buffer (pH 8.0). After addition of 850mg 
PA/Eupergit C, the mixture was rotated at 35°C for 25 h. No cleavage of Phac-group 
was observed but Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 was obtained in an isolated 
yield of 40.2%. 
 
(33) Cleavage Phac-group from Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 via 
PGA/Eupergit C 
80 mg (0.1 mmol) Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were suspended in 10 ml 1 
M KH2PO4 buffer (pH 7.5) and 2.4 ml EtOH. After addition of 200 mg PGA/Eupergit 
C, the mixture was rotated at 35°C for 24 h. To extract the product, the mixture was 
diluted with 50 ml 80% MeOH, sonicated, and filtered. The filtrate was evaporated to 
dryness under vacuum. The residue was separated by MPLC. The pooled fractions 
were lyophilized twice yielding a white powder Gly-Trp-Met-Asp(OMe)-Phe-NH2 
(16 mg, 24.0%, decomposition at 210oC, HPLC system 6 with tR 9.13, FABMS m/z 
668.0 [M+H+], m/z 690.2 [M+Na+], C32H41N7O7S1 requires 667.8). 
 
(34) Cleavage Phac-group from Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 via 
PGA/Eupergit C (Xiang et al. 2004) 
0.2g (0.26 mmol) Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2 were suspended in 10 ml 
H2O and the pH was adjusted with 1M NaOH to 7.6. After addition of 0.4 g 
PGA/Eupergit C, the mixture was rotated at 35°C for 24 h. To extract the product, the 
mixture was diluted with 20 ml 80% EtOH, sonicated, and filtered. The filtrate was 
evaporated to dryness under vacuum. The residue was separated by preparative HPLC 
with an eluent of 60% B. The residue was dissolved in 5 ml 60% B and the desired 
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product was eluted as the second peak. The pooled fractions were lyophilized twice 
yielding a white powder Gly-Trp-Met-Asp-Phe-NH2 (32 mg, 18.8%, decomposition at 
230ºC, HPLC system 6 with tR 6.73, FABMS m/z 654.2 [M+H+], m/z 676.2 [M+Na+], 
C31H39N7O7S1 requires 653.7). 
 
(35) Synthesis of Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 via 
α-CHY/Eupergit C 
To a solution of 60 mg (0.1 mmol) Phac-Asp(OMe)-Tyr-Met-OAl and 31 mg (0.046 
mmol) Gly-Trp-Met-Asp(OMe)-Phe-NH2 in 5 ml ACN containing 25 µl 0.05 M 
Tris-HCl buffer (pH 9.0) and 25 µl Et3N, 100 mg α-CHY/Eupergit C were added. The 
reaction mixture was rotated at room temperature. The reaction was monitored by 
HPLC (system 6). After 63 h, the total HPLC yield (25.8%) of a group of new peaks 
with tR from11.99 to 12.47 (HPLC system 7) was obtained. To extract the products, 
the mixture was diluted with 50 ml 80% MeOH, sonicated, and filtered. The filtrate 
was evaporated to dryness under vacuum. The residue was separated by preparative 
HPLC with an eluent of 85% B. The pooled fractions of the new substances were 
lyophilized twice yielding a white powder (14 mg, 25.2%). LC-ESIMS was used to 
investigate the mixture of new substances (LC-ESIMS: compound 1 (product) 
Phac-Asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2, HPLC system in 
LC-ESIMS with tR 15.253 (44.9%); ESIMS: 14.0 min, m/z 1209.6 [M+H+], m/z 
1231.7 [M+Na+], C59H72N10O14S2 requires 1208.9. Presumed compound 2 and 
compound 3, HPLC system in LC-ESIMS with tR 15.675 (55.1%). ESIMS of 
presumed compound 2: 14.5 min, m/z 1177.5 [M+H+], m/z 1199.5 [M+Na+], 
C58H68N10O13S2 requires 1176.6. ESIMS of presumed compound 3:14.8 min, m/z 
1145.5 [M+H+], m/z 1167.6 [M+Na+], C57H64N10O12S2 requires 1145.6 (Figure 3.18 – 
3.21). The product Phac-asp(OMe)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was 
obtained in a HPLC yield of 11.5%.
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5 Summary 
 
Enzymes can be used often favorably in organic syntheses, because they can be 
applied at room or slightly elevated temperature and in aqueous phase. Therefore 
these enzymatically catalyzed reactions are economically and environmentally 
superior to classical organic reactions. The objective of this thesis is to develop a 
synthetic path to the cholecystokinin octapeptide CCK-8 using exclusively enzymatic 
methods. The fragment CCK-8 has nearly the full biological activity of 
cholecystokinin and its therapeutic potential against type 2 diabetes, obesity and 
epilepsy is studied intensively. 
 
During the coupling process, many side reactions observed in the chemical peptide 
synthesis can be avoided in the enzymatic peptide synthesis. However, each coupling 
reaction has to be optimized. That means the optimal strategy, substrate structure and 
concentration, reaction media and temperature, type of the protease and its support for 
enzyme deposition. 
 
In the synthesis of the N-terminal tripeptide fragment Phac-Asp(OMe)-Tyr-Met-OAl, 
two strategies (Scheme 3.5, Scheme 3.6) with stepwise peptide chain elongation from 
the N-terminus to the C-terminus were investigated. Because of less reaction steps, 
higher overall yield and more economic starting materials, the second strategy was 
superior to be integrated in the final CCK-8 assembly. Compared to the reported 
synthesis of the tripeptide fragment Phac-Asp(OBut)-Tyr-Met-OAl (Fite et al., 2002) 
in the second strategy two reaction steps could be avoided to synthesize an OCam 
ester and an overall yield of 45% of Phac-Asp(OMe)-Tyr-Met-OAl could be obtained. 
 
The pentapeptide fragment CCK-5 was synthesized by a stepwise N→C coupling 
strategy using the enzymes papain, α-chymotrypsin, thermolysin and penicillin G 
amidase. 
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In comparison with earlier developed syntheses of CCK-5 in our laboratory (Xiang et 
al., 2004) and in another group (Fite et al., 2002) several chemical reaction steps 
could be circumvented. But still one OCam ester was necessary. In the coupling with 
Met-OEt·HCl as nucleophile in a solvent free system, the OMe ester of 
Phac-Gly-Trp-OMe could be used directly as acyl-donor. Thus three reaction steps, 
otherwise necessary for the preparation of an OCam ester as reported (Capellas et al., 
1996), could be avoided. 
 
Except of the Asp-Phe coupling using free thermolysin, all other peptide couplings 
and the cleavage of the Phac-group at the end of the synthesis could be performed 
with covalently immobilized enzymes. This is important for the large scale synthesis 
of peptides and for therapeutical applications. 
 
According to the literature, it is necessary that acyl-donors need to carry an ester 
group to form the acyl-enzyme with serine or cysteine proteases. However, in this 
work and also in earlier investigations in our group we observed that quite often 
peptide fragments with free carboxyl groups are good acyl-donors for couplings with 
papain and α-chymotrypsin. For the elongation of Phac-Gly-Trp-Met-OH to the 
tetrapeptide Phac-Gly-Trp-Met-Asp(OMe)-OH, the free carboxyl group of the 
acyl-donor was necessary. Neither an alkyl ester nor the usually most reactive OCam 
ester was a useful substrate for papain. 
  
The final fragment condensation of the tripeptide Phac-Asp(OMe)-Tyr-Met-OAl and 
the pentapeptide Gly-Trp-Met-Asp(OMe)-Phe-NH2 could be achieved with 
α-chymotrypsin/Eupergit C. According to LC-ESIMS the condensation reaction was 
quite effective. The protected CCK-8 peptide was formed in the HPLC yield of 11.5%. 
A by-product was an octapeptide with 32 mass units less. Most likely one of the 
ß-esters of the aspartic acid residue underwent a ring closure reaction, quite often 
observed as one of the most common side reactions of aspartic acid moieties under 
basic conditions. Another by-product with 64 mass units less was probably formed 
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when both aspartic acid residues underwent ring closure reactions. It will need further 
investigation to avoid these side reactions. 
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7 Appendix 
FABMS spectra 
(1) Phac-Asp(OMe)-OCam, [M+H+]=323.0, [M+Na+]=355.2 
 
(2) Phac-Asp(OMe)-Tyr-OAl, [M+H+]=469.0, [M+Na+]=491.1 
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(3) Phac-Asp(OMe)-Tyr-Tyr-OAl, [M+H+]=632.2, [M+Na+]=654.1 
 
 
(4) Phac-Asp(OMe)-Tyr-OMe, [M+H+]=443.1, [M+Na+]=465.0 
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(5) Phac-Asp(OMe)-Tyr-OH, [M+H+]=429.1, [M+Na+]=451.0 
 
 
(6) Phac-Asp(OMe)-Tyr-Met-OAl, [M+H+]=600.2, [M+Na+]=622.2 
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(7) Phac-Asp(OMe)-Tyr-Met-Met-OAl, [M+H+]=731.2, [M+Na+]=753.2 
 
 
(8) Asp(OMe)-Phe-NH2, [M+H+]=294.1, [M+Na+]=316.1 
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(9) Fmoc-Met-Asp(OMe)-Phe-NH2, [M+H+]=647.0, [M+Na+]=669.2. 
 
 
(10) Met-Asp(OMe)-Phe-NH2, [M+H+]=425.0, [M+Na+]=447.0 
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(11) Fmoc-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=833.2, [M+Na+]=855.5 
 
 
(12) Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=611.1 
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(13) Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=890.3, [M+Na+] =912.2 
 
 
(14) Phac-Gly-Trp-OH, [M+H+]=380.2, [M+Na+]=402.1 
 
 
 
 
134                        7 Appendix 
(15) Phac-Gly-Trp-OMe, [M+H+]=394.1 
 
 
(16) Phac-Gly-Trp-Met-OAl, [M+H+]=551.1 
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(17) Phac-Gly-Trp-Met-OEt, [M+H+]=539.1, [M+Na+]=561.2 
 
 
(18) Phac-Gly-Trp-Met-Asp(OMe)-OMe, [M+H+]=654.1, [M+Na+] =676.0 
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(19) Phac-Gly-Trp-Met-Asp(OMe)-OH, [M+H+]=640.2, [M+Na+]=662.1 
 
 
(20) Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+Na+]=808.1 
 
 
 
7 Appendix                              137 
(21) Phac-Gly-Trp-Phe-NH2, [M+H+]=526.2, [M+Na+]=548.1 
 
 
(22) Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=668.0, [M+Na+]=690.2 
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